{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":130,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":130,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"af7a8fbc2407","filters":{"venue":"Expert Opinion on Investigational Drugs"}},"results":[{"id":"W2103567156","doi":"10.1517/13543784.15.8.933","title":"Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":432,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Cytotoxicity; Cancer cell; Lytic cycle; Cancer; Angiogenesis; Antimicrobial; Cancer research; Cytotoxic T cell; Apoptosis; Biology; Chemotherapy; Drug resistance; Drug; Pharmacology; Immunology; In vitro; Microbiology; Biochemistry","authors":[{"name":"Jamie S. Mader","is_ca":true},{"name":"David W. Hoskin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08353260939165319,"gpt":0.3646609990887729,"spread":0.2811283896971197,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001168029,0.000773954,0.001294098,0.0002913445,0.0005821217,0.00007877257,0.0003497546,0.0006629867,0.0002904657],"category_scores_gemma":[0.00005865786,0.0006448445,0.000785578,0.0001786002,0.0004576665,0.0001499199,0.00006536371,0.000291308,0.0006430728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007025276,"about_ca_system_score_gemma":0.001312377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001134562,"about_ca_topic_score_gemma":0.00002189104,"domain_scores_codex":[0.9976047,0.0001414984,0.0008024253,0.0008247766,0.00009521654,0.0005313362],"domain_scores_gemma":[0.9983765,0.0004671559,0.0006113285,0.0003617413,0.0001210942,0.00006215715],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001233124,0.001344202,0.000005243094,0.002819174,0.001770592,0.000001498682,0.0009684347,0.0001515583,0.006696333,0.03063847,0.5564132,0.3990679],"study_design_scores_gemma":[0.001021842,0.0001927073,0.000004657151,0.004756559,0.00007241561,0.0000344764,0.00002953907,0.000002921529,0.003310338,0.0001545503,0.9897767,0.0006432688],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001021259,0.9899548,0.00006318697,0.0007192303,0.003338715,0.001950512,0.002882311,0.0001236839,0.0008654012],"genre_scores_gemma":[0.00007990214,0.9649484,0.0004370156,0.001030559,0.001099693,0.001605144,0.01407028,0.0001160322,0.01661295],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4333635,"threshold_uncertainty_score":0.9996003,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152775636","doi":"10.1517/13543784.12.4.663","title":"Pregabalin: a new anxiolytic","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":316,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Pregabalin; Gabapentin; Anticonvulsant; Pharmacology; Anxiolytic; Neuropathic pain; Medicine; Epilepsy; Anesthesia; Anxiety; Psychiatry","authors":[{"name":"Bianca Lauria-Horner","is_ca":true},{"name":"Robert Pohl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2469151906030161,"gpt":0.4506774258193225,"spread":0.2037622352163064,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002989388,0.0006452852,0.0009403423,0.0005530118,0.0004347152,0.0001644499,0.001153681,0.0003087794,0.0005518044],"category_scores_gemma":[0.001326917,0.0005340384,0.0004224822,0.001330584,0.0007111566,0.0002865794,0.0001853889,0.001090912,0.002583071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001752938,"about_ca_system_score_gemma":0.002443605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004813684,"about_ca_topic_score_gemma":4.852537e-8,"domain_scores_codex":[0.9944822,0.001219866,0.0007275835,0.001561541,0.001300354,0.0007084214],"domain_scores_gemma":[0.9966946,0.001580383,0.0003426429,0.0006058508,0.00004367431,0.0007328245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003175544,0.0003637779,6.21915e-7,0.001304343,0.00002506759,0.00009068142,0.0003233163,0.00001340984,0.003159684,0.04412086,0.3546812,0.5958853],"study_design_scores_gemma":[0.0002969068,0.0001510948,2.056723e-7,0.001771076,0.000006630872,0.0001311036,0.000003186673,0.00002920933,0.004144611,0.0008655617,0.9921332,0.0004672062],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008507431,0.9885571,0.000008278354,0.001220878,0.003745697,0.00128939,0.00005937274,0.0001705174,0.004940277],"genre_scores_gemma":[0.000004401425,0.9790453,0.00006098583,0.01180799,0.0008936191,0.000310572,0.00002278916,0.0000975023,0.007756868],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.637452,"threshold_uncertainty_score":0.9997111,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2166753714","doi":"10.1517/13543780902832661","title":"Cathepsin K inhibitors for osteoporosis and potential off-target effects","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":209,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Canada Research Chairs","keywords":"Cathepsin K; Cathepsin; Osteoporosis; Medicine; Cathepsin A; Cancer research; Pharmacology; Chemistry; Biochemistry; Internal medicine; Osteoclast; Enzyme; In vitro","authors":[{"name":"Dieter Brömme","is_ca":true},{"name":"Fabien Lecaille","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01784050697919237,"gpt":0.3063636798781626,"spread":0.2885231728989702,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000182848,0.0004280425,0.0006249883,0.0001106034,0.000158927,0.00005373542,0.0001684827,0.0003764509,0.000006949631],"category_scores_gemma":[0.0002933358,0.000369656,0.0003923864,0.00008629587,0.0001550429,0.000007555342,0.00007106873,0.0001085125,0.00001006096],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001999258,"about_ca_system_score_gemma":0.0003603019,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005652784,"about_ca_topic_score_gemma":1.755311e-7,"domain_scores_codex":[0.998286,0.000187984,0.0003982327,0.0006351206,0.0002466246,0.0002460164],"domain_scores_gemma":[0.9990569,0.0001057784,0.0002215249,0.000291349,0.00007284774,0.0002516282],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007582001,0.0001706109,0.000002134833,0.0022016,0.0001352341,0.000001137165,0.0001004359,0.000006935974,0.0005188991,0.001752087,0.1135506,0.8814845],"study_design_scores_gemma":[0.000498941,0.0002078609,0.00002133334,0.001434338,0.00003962671,0.000007511745,0.00001132406,0.000006405849,0.001084501,0.0006917079,0.9955862,0.0004102393],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001180291,0.997381,0.00006718462,0.0002235435,0.0009015498,0.000877651,0.0002948602,0.00002130518,0.000114934],"genre_scores_gemma":[0.00007943729,0.9879368,0.002008322,0.001140296,0.002388121,0.0004369887,0.005744607,0.00005680949,0.0002085993],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8820356,"threshold_uncertainty_score":0.9998755,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112228502","doi":"10.1517/13543784.12.1.87","title":"Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Investigational Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Incretin; Dipeptidyl peptidase; Aminopeptidase; Peptide; Glucagon-like peptide-1; Dipeptidyl peptidase-4; Type 2 diabetes; Sitagliptin; Chemistry; Pharmacology; Biochemistry; Endocrinology; Internal medicine; Biology; Diabetes mellitus; Medicine; Enzyme; Amino acid","authors":[{"name":"Daniel J. Drucker","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02959327137273806,"gpt":0.2913622153120864,"spread":0.2617689439393484,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001130542,0.0001637222,0.0002382696,0.00009350189,0.00007788175,0.000008051818,0.00005887868,0.00004773603,0.00009327319],"category_scores_gemma":[0.00005302752,0.000102078,0.000172411,0.0001498196,0.0001885989,0.00004440566,0.000007255219,0.00003012075,0.00001005461],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007191397,"about_ca_system_score_gemma":0.00009293218,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008814109,"about_ca_topic_score_gemma":2.324578e-7,"domain_scores_codex":[0.9990109,0.00004346208,0.0002840838,0.00018945,0.0003070289,0.0001650613],"domain_scores_gemma":[0.9991738,0.0002492202,0.0001301058,0.0002395091,0.0001293581,0.00007799614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001957906,0.01478818,0.03877084,0.0007143906,0.007178521,0.000003994989,0.0154251,0.002325482,0.12606,0.5154888,0.08388976,0.193397],"study_design_scores_gemma":[0.009369196,0.00884313,0.01622108,0.0004487315,0.0002186479,0.000001192477,0.001339104,0.002528124,0.3341505,0.006678834,0.6198019,0.0003995658],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9728742,0.01239639,0.0001539565,0.006621084,0.002009132,0.002811562,0.00005311198,0.00006273548,0.003017802],"genre_scores_gemma":[0.9956123,0.001139748,0.001114712,0.0007221462,0.0002301037,0.0002455945,0.0001746717,0.00002327479,0.0007374305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5359122,"threshold_uncertainty_score":0.4162621,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017150135","doi":"10.1517/13543784.14.8.1019","title":"Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Angiotensin II receptor type 1; Renin–angiotensin system; Angiotensin II; Receptor; Angiotensin receptor; Angiotensin-converting enzyme; Pharmacology; Internal medicine; Biology; Chemistry; Endocrinology; Medicine; Blood pressure","authors":[{"name":"Robson A.S. Santos","is_ca":false},{"name":"Anderson J. Ferreira","is_ca":false},{"name":"Sérgio VB Pinheiro","is_ca":false},{"name":"Walkyria Oliveira Sampaio","is_ca":false},{"name":"Rhian M. Touyz","is_ca":true},{"name":"Maria José Campagnole‐Santos","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06479758894437689,"gpt":0.3517893935821556,"spread":0.2869918046377787,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005973031,0.001033094,0.003278921,0.0005138678,0.0003458394,0.00008507787,0.0002388833,0.0007275337,0.00008829096],"category_scores_gemma":[0.0008013818,0.0008593224,0.00222394,0.0003953833,0.0002235886,0.0001608456,0.0001597845,0.0004795308,0.0004719324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004255775,"about_ca_system_score_gemma":0.001488266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005754739,"about_ca_topic_score_gemma":2.468057e-7,"domain_scores_codex":[0.9950603,0.000282069,0.001223334,0.001368126,0.001446528,0.0006196365],"domain_scores_gemma":[0.9970089,0.000425583,0.0004996688,0.0007283095,0.0005553566,0.0007822184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008953478,0.00007082307,9.489318e-7,0.001415329,0.003298676,0.00001019036,0.001261575,0.00001320638,0.00001334392,0.002357621,0.3571716,0.6342972],"study_design_scores_gemma":[0.001580059,0.0002522886,0.00001506548,0.01370662,0.000438235,0.0002819193,0.00005268915,0.00005848096,0.00004031523,0.0001390937,0.9826729,0.000762291],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008743563,0.9864373,0.0000840868,0.006522428,0.002410843,0.003623349,0.0001551277,0.0001723386,0.0005857674],"genre_scores_gemma":[0.00002187221,0.974024,0.007804316,0.001642385,0.01066184,0.0005032729,0.001722956,0.000227189,0.003392187],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6335349,"threshold_uncertainty_score":0.9993858,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152749001","doi":"10.1517/13543784.12.3.353","title":"Aromatase inhibitors for the treatment of infertility","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Ovarian function and disorders","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Ovarian hyperstimulation syndrome; Ovulation induction; Infertility; Ovulation; Medicine; Aromatase; Follicular phase; Internal medicine; Endocrinology; Polycystic ovary; Letrozole; Anovulation; Pregnancy; Hormone; Biology; In vitro fertilisation; Insulin; Insulin resistance","authors":[{"name":"Mohamed FM Mitwally","is_ca":true},{"name":"Robert F. Casper","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1071983697560836,"gpt":0.3850609297580475,"spread":0.277862560001964,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001711438,0.0003387622,0.0008239013,0.0001533448,0.0001263857,0.00001387678,0.00008233202,0.0002113237,0.0002161239],"category_scores_gemma":[0.0002371203,0.0001980324,0.000635543,0.0002402767,0.0002293222,0.00003512939,0.000008050213,0.0001101811,0.00005680812],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002066943,"about_ca_system_score_gemma":0.000815327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002278203,"about_ca_topic_score_gemma":3.543745e-7,"domain_scores_codex":[0.998365,0.0001100659,0.0006504706,0.0003539283,0.0003581537,0.00016236],"domain_scores_gemma":[0.9982033,0.00076336,0.0002924651,0.0004674476,0.0001045859,0.0001688051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001346364,0.001148305,0.00001856186,0.002603827,0.0005102776,5.755617e-7,0.0006475378,0.000005236588,9.541236e-7,0.0158513,0.1255155,0.8535632],"study_design_scores_gemma":[0.001179579,0.0005275815,0.00002236137,0.001925426,0.0000833211,0.000006439532,0.00008484134,0.00001756673,0.00002014421,0.0003486712,0.995627,0.000156997],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002833425,0.9938554,0.00006747869,0.001239495,0.001440137,0.002088243,0.0002220469,0.00003415935,0.001050218],"genre_scores_gemma":[0.00000527075,0.9942351,0.0004690926,0.001147143,0.0004860764,0.001050642,0.001996378,0.0000382741,0.0005720498],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8701115,"threshold_uncertainty_score":0.8075525,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2054297512","doi":"10.1517/13543780902980171","title":"Sunitinib in solid tumors","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sunitinib; GiST; Medicine; Sorafenib; Everolimus; Renal cell carcinoma; Imatinib; Tyrosine-kinase inhibitor; Bevacizumab; Oncology; Pharmacology; Internal medicine; Cancer; Stromal cell; Hepatocellular carcinoma; Chemotherapy","authors":[{"name":"Hui Gan","is_ca":true},{"name":"Boštjan Šeruga","is_ca":true},{"name":"Jennifer J. Knox","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1198872661313079,"gpt":0.4374837508832138,"spread":0.3175964847519059,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002934353,0.0005359888,0.001441719,0.0007125794,0.00008481251,0.00003920204,0.0002056272,0.0001510037,0.000221307],"category_scores_gemma":[0.0005928483,0.0004177009,0.0004024968,0.0005395794,0.0001948186,0.00007055863,0.00005156886,0.0008179904,0.000642366],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005839258,"about_ca_system_score_gemma":0.001572863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005083331,"about_ca_topic_score_gemma":0.000001227496,"domain_scores_codex":[0.996892,0.0002389048,0.000837638,0.0006077697,0.0009011715,0.0005225027],"domain_scores_gemma":[0.9982629,0.0003783182,0.0002343949,0.0004104,0.0001175082,0.0005964278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008974958,0.000924706,0.0000480306,0.002645295,0.0001092083,0.000540145,0.0002155285,0.000004259125,0.000002038604,0.01123635,0.01866924,0.9655154],"study_design_scores_gemma":[0.0008708921,0.0008190931,0.0002482451,0.04875133,0.00001267935,0.000552902,0.00003928864,0.0000175452,0.00001301634,0.0008088436,0.9475757,0.0002904282],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003124723,0.9887096,0.000002206533,0.001982032,0.0001661301,0.001287245,0.00004925338,0.00008140392,0.00769089],"genre_scores_gemma":[0.00006126612,0.9932092,0.001486298,0.001075798,0.0006829968,0.0004268965,0.002355772,0.00006528357,0.0006365241],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.965225,"threshold_uncertainty_score":0.9998275,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1970919362","doi":"10.1517/13543784.11.8.1061","title":"Cytokine modulation in sepsis and septic shock","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Macrophage Migration Inhibitory Factor","field":"Immunology and Microbiology","cited_by":113,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Sepsis; Medicine; Septic shock; Cytokine; Proinflammatory cytokine; Tumor necrosis factor alpha; Immunology; Inflammation","authors":[{"name":"Sergio Zanotti","is_ca":false},{"name":"Anand Kumar","is_ca":true},{"name":"Aseem Kumar","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05579661714413267,"gpt":0.3200596065372179,"spread":0.2642629893930852,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001926834,0.000500125,0.0009106357,0.0005376287,0.0001740712,0.00003832467,0.0001948382,0.0006754558,0.001522204],"category_scores_gemma":[0.0001774067,0.0004514977,0.0001934089,0.0003274351,0.0002634296,0.0001478195,0.00007590075,0.0005832886,0.001163542],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002434339,"about_ca_system_score_gemma":0.000145108,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003632123,"about_ca_topic_score_gemma":0.000003110767,"domain_scores_codex":[0.9975308,0.0005201619,0.0008463448,0.00067617,0.0001305859,0.000295929],"domain_scores_gemma":[0.9987375,0.0004626587,0.0003463728,0.000328814,0.00005931202,0.00006531391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003003846,0.0003110913,0.00005691181,0.002341122,0.0002998021,0.000006238631,0.003253391,0.00006612932,0.0005257384,0.0108382,0.1214879,0.8607834],"study_design_scores_gemma":[0.0005102434,0.00005930534,0.00007214534,0.003481837,0.000009959909,0.0000260719,0.00003261907,0.00007178788,0.00006694023,0.0001997771,0.9950562,0.0004130997],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001306027,0.9965344,0.0000154358,0.0003206638,0.001382289,0.0006959109,0.0001643629,0.00007943133,0.0006768935],"genre_scores_gemma":[0.0005826704,0.9933694,0.000168867,0.0004691197,0.0002899617,0.0003379723,0.002536925,0.00006025894,0.002184833],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8735683,"threshold_uncertainty_score":0.9997936,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003487329","doi":"10.1517/13543784.16.4.519","title":"Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Cardiome Pharma Corp.","keywords":"Medicine; Atrial fibrillation; Cardiology; Sinus rhythm; Internal medicine; Exacerbation; Ranolazine; Anti-Arrhythmia Agents","authors":[{"name":"David Fedida","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08118196522207384,"gpt":0.3816794494545254,"spread":0.3004974842324515,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004301833,0.0007086266,0.002002001,0.0005099154,0.0002412574,0.00002713355,0.0001633878,0.0007276771,0.0001069979],"category_scores_gemma":[0.0003323767,0.0005853684,0.001572379,0.0005919575,0.0003739047,0.00007678213,0.00008330193,0.0009829309,0.0006506368],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006788185,"about_ca_system_score_gemma":0.001880651,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002495883,"about_ca_topic_score_gemma":2.541133e-7,"domain_scores_codex":[0.9965562,0.0002138888,0.0009238647,0.0009485418,0.0008112214,0.0005462879],"domain_scores_gemma":[0.9976316,0.0007050167,0.0004908059,0.0005548113,0.0001899006,0.0004278384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000597849,0.0002706666,0.000009999947,0.00385784,0.00274706,0.0001826076,0.0008113337,0.0000435647,0.0001874721,0.02421288,0.1231654,0.8439133],"study_design_scores_gemma":[0.0008279827,0.0003767438,0.00005854953,0.008119796,0.0001017234,0.0005783351,0.0000127802,0.00001124201,0.00008582317,0.0001708689,0.9891187,0.0005374498],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007116547,0.9915122,0.00003221419,0.000393523,0.002996741,0.001285707,0.0001236542,0.0001468958,0.003437941],"genre_scores_gemma":[0.00006300014,0.9864345,0.0005063521,0.001863729,0.008278114,0.00010699,0.001937004,0.0001152543,0.0006950576],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8659533,"threshold_uncertainty_score":0.9996598,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2103370158","doi":"10.1517/13543784.13.3.199","title":"Recent advances in protein tyrosine phosphatase 1B inhibitors","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Downregulation and upregulation; Leptin; Insulin resistance; Protein tyrosine phosphatase; Insulin; Type 2 diabetes; Diabetes mellitus; Obesity; Insulin receptor; Biology; Phosphatase; Tyrosine; Internal medicine; Endocrinology; Medicine; Cell biology; Biochemistry; Phosphorylation","authors":[{"name":"Scott D. Taylor","is_ca":true},{"name":"Bryan Hill","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02731105292417839,"gpt":0.3292266025047831,"spread":0.3019155495806047,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002936205,0.000697993,0.0007989698,0.0002231783,0.0001147935,0.00005273731,0.0004952666,0.0004816224,0.00006501692],"category_scores_gemma":[0.0005554236,0.0006393303,0.0002606545,0.0004761562,0.0002915066,0.000029237,0.0002130672,0.0004019357,0.0001171821],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002919633,"about_ca_system_score_gemma":0.00131836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002522417,"about_ca_topic_score_gemma":0.000004283845,"domain_scores_codex":[0.9968299,0.0002202435,0.000922489,0.001040596,0.0005471499,0.0004396341],"domain_scores_gemma":[0.9984658,0.00004537814,0.0004834538,0.000644896,0.0001085072,0.0002519099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006525749,0.0003166884,0.000001516989,0.002140887,0.0000438162,0.000007293231,0.0000381755,0.0000708251,0.00007371845,0.02201715,0.01131588,0.9639088],"study_design_scores_gemma":[0.0007127312,0.0002116647,0.000001015844,0.0156605,0.000005303069,0.000009914517,0.000008677989,0.000001188552,0.02682434,0.0008156177,0.9551011,0.0006479805],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000003320579,0.9962204,0.00002119078,0.0004656556,0.00077536,0.001711943,0.0005868828,0.00003664018,0.0001786267],"genre_scores_gemma":[0.000009557979,0.980442,0.001412347,0.0005684903,0.0009945187,0.00173057,0.01464063,0.000103117,0.00009880668],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9632608,"threshold_uncertainty_score":0.9996058,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116152202","doi":"10.1517/13543784.11.7.991","title":"Bosentan: a dual endothelin receptor antagonist","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Bosentan; Endothelin receptor antagonist; Medicine; Endothelin receptor; Pulmonary hypertension; Tolerability; Internal medicine; Cardiology; Pharmacology; Receptor; Adverse effect","authors":[{"name":"Sébastiên Roux","is_ca":false},{"name":"Lewis J. Rubin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.109545352175218,"gpt":0.3838684803300484,"spread":0.2743231281548305,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001828921,0.0006771828,0.001520782,0.0004633837,0.0002698973,0.000060741,0.00020501,0.0004075081,0.002230538],"category_scores_gemma":[0.000298418,0.0005012311,0.0006741532,0.0004182345,0.0003349482,0.0001037624,0.00009688393,0.000722051,0.006828274],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000443508,"about_ca_system_score_gemma":0.000864711,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002652132,"about_ca_topic_score_gemma":1.485629e-7,"domain_scores_codex":[0.9961541,0.0002951864,0.0008005932,0.0008615782,0.001358054,0.0005304908],"domain_scores_gemma":[0.9976538,0.0004218348,0.0002676068,0.0006233308,0.0001593796,0.0008739791],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001098406,0.001330059,0.00001275686,0.00218221,0.0006978691,0.0005282109,0.0001139309,2.227947e-7,0.00002241815,0.003010219,0.3766941,0.6152982],"study_design_scores_gemma":[0.001083197,0.0003762508,0.000005578653,0.01039347,0.00004030015,0.0006170204,0.00002646226,0.00002940592,0.0000331109,0.00009970864,0.9869014,0.0003940983],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000006076019,0.9867821,0.000001093866,0.003153767,0.001016755,0.001319403,0.0005939015,0.0001326387,0.006994242],"genre_scores_gemma":[0.000005859024,0.9773212,0.001037037,0.002248589,0.001736427,0.0005687647,0.005806365,0.0001190924,0.01115666],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.614904,"threshold_uncertainty_score":0.9997439,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047925472","doi":"10.1517/13543780903282759","title":"Darinaparsin: a novel organic arsenical with promising anticancer activity","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Arsenic trioxide; Acute promyelocytic leukemia; In vivo; Cancer research; Arsenic; Pharmacology; Broad spectrum; Leukemia; In vitro; Chemistry; Medicine; Biology; Biochemistry; Immunology; Retinoic acid; Combinatorial chemistry","authors":[{"name":"Koren K. Mann","is_ca":true},{"name":"Barbara Wallner","is_ca":false},{"name":"Izidore S. Lossos","is_ca":false},{"name":"Wilson H. Miller","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04489331870199863,"gpt":0.3385623228525425,"spread":0.2936690041505439,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001856952,0.0005367465,0.0007195987,0.00008380691,0.000190228,0.00007729958,0.000381829,0.0005093581,0.00003504434],"category_scores_gemma":[0.0001573765,0.0004187434,0.0002297622,0.0002596861,0.0003509223,0.00001128281,0.00009373004,0.0004367243,0.00002893939],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001373906,"about_ca_system_score_gemma":0.001915053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000573086,"about_ca_topic_score_gemma":7.37697e-7,"domain_scores_codex":[0.9977517,0.0001275768,0.0003973622,0.0008928243,0.0004986683,0.0003318392],"domain_scores_gemma":[0.9987446,0.00006454322,0.0003353813,0.0005334974,0.0001222648,0.0001997248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002605519,0.0008135847,0.0000110707,0.003649658,0.0005624914,0.00001007979,0.0002153133,0.00003465004,0.01813963,0.004124293,0.01367728,0.9585014],"study_design_scores_gemma":[0.0004058078,0.0003430071,0.000008960059,0.004055108,0.0000241749,0.0000895238,0.000008452489,0.0000144603,0.006419908,0.00007832107,0.9879847,0.0005676348],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004945318,0.9952095,0.001080206,0.0003303049,0.0003568024,0.000609131,0.00004168837,0.00004109126,0.001836754],"genre_scores_gemma":[0.0006694705,0.9931915,0.002465012,0.000644755,0.001375374,0.0001332078,0.001042377,0.00008790634,0.000390333],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9743074,"threshold_uncertainty_score":0.9998264,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4232214719","doi":"10.1517/13543784.9.7.1511","title":"Psoriatic arthritis","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Psoriatic arthritis; Medicine; Rheumatoid arthritis; Arthritis; Psoriasis; Dactylitis; Inflammatory arthritis; Immunology; Osteolysis; Cytokine; Pathogenesis; Dermatology; Enthesitis; Surgery","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05957936896122606,"gpt":0.3699500060783316,"spread":0.3103706371171055,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002263992,0.0004995594,0.001421118,0.0004318523,0.0002037565,0.00008450356,0.0002209653,0.0003124998,0.002468834],"category_scores_gemma":[0.0002346256,0.0004106381,0.000550952,0.0003682209,0.0003282455,0.0001146229,0.00003842039,0.0006515547,0.002852284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001695124,"about_ca_system_score_gemma":0.001211056,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003286445,"about_ca_topic_score_gemma":6.080753e-7,"domain_scores_codex":[0.996873,0.0002601302,0.000788024,0.0005865391,0.00105712,0.0004351401],"domain_scores_gemma":[0.9983243,0.00035404,0.0001813997,0.0005030251,0.00008914719,0.0005480524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000205179,0.00009387219,2.743888e-7,0.0006989719,0.0001399419,0.00001201081,0.0002105102,3.363195e-7,1.481241e-7,0.006016375,0.06263646,0.9301706],"study_design_scores_gemma":[0.0008435919,0.000222513,0.000002287707,0.04244386,0.000002932806,0.0001714521,0.00001950217,0.0000120758,0.000003242182,0.001458199,0.9544801,0.0003402909],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00000214387,0.9881025,0.000003984649,0.001510154,0.0006888491,0.0009568244,0.00009265661,0.0001372486,0.008505638],"genre_scores_gemma":[0.000003163918,0.9929734,0.0004916731,0.001597863,0.001390844,0.0006200126,0.001958797,0.0001011351,0.0008631198],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9298303,"threshold_uncertainty_score":0.9998345,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2150692587","doi":"10.1517/13543784.2013.769957","title":"5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":63,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Schizophrenia (object-oriented programming); Psychiatry; Antipsychotic; Psychosis; Anxiety; Mood disorders; Dementia; Psychology; Management of schizophrenia; Depression (economics); 5-HT2A receptor; Medicine; Disease; Serotonin; 5-HT receptor; Internal medicine","authors":[{"name":"Tiago Mestre","is_ca":true},{"name":"Mateusz Zurowski","is_ca":true},{"name":"Susan H. Fox","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03747977311721774,"gpt":0.3762715629305328,"spread":0.3387917898133151,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0001618212,0.001353364,0.001818176,0.0007745186,0.0005027126,0.0001446348,0.0007768424,0.0008289555,0.0052252],"category_scores_gemma":[0.0001264134,0.001157874,0.001393017,0.0006604407,0.0004517689,0.0001808234,0.00007986891,0.0004859416,0.006454092],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007052305,"about_ca_system_score_gemma":0.0008252535,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004562368,"about_ca_topic_score_gemma":0.00000505916,"domain_scores_codex":[0.9947633,0.0005343544,0.001349256,0.001749587,0.0006997007,0.0009038663],"domain_scores_gemma":[0.9966817,0.0006416828,0.001055422,0.0009889405,0.0001316692,0.0005005331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006832925,0.0008752931,0.00000636235,0.0006658573,0.000714362,0.000001320322,0.0007659003,0.00001157745,0.000001770613,0.05230192,0.1453354,0.799252],"study_design_scores_gemma":[0.002222096,0.001301916,0.00002195322,0.001152385,0.00008314502,0.00001894206,0.0002643409,0.00003133358,0.000003941363,0.004806125,0.9889614,0.001132434],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003380717,0.9698151,0.0001539025,0.003953937,0.01304296,0.004982347,0.0006417072,0.0002407858,0.007135421],"genre_scores_gemma":[0.00003242855,0.9720803,0.002602699,0.0008961342,0.003393817,0.007333589,0.008662015,0.0003141632,0.004684873],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.843626,"threshold_uncertainty_score":0.9999217,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095549754","doi":"10.1517/13543780903179294","title":"Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Business Development Bank of Canada","funders":"","keywords":"Medicine; Asthma; COPD; Disease; Inflammation; Intensive care medicine; Immunology; Internal medicine","authors":[{"name":"Rosanne Séguin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07718330351801966,"gpt":0.4155367821951554,"spread":0.3383534786771357,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003690807,0.0005463474,0.001090349,0.0004754846,0.0003316304,0.00004782574,0.0002118648,0.0002410678,0.0000868007],"category_scores_gemma":[0.0005942349,0.0004550643,0.0003552647,0.0003162076,0.0003890998,0.0001600917,0.00007820483,0.0006087752,0.00005191891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007172807,"about_ca_system_score_gemma":0.002917443,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009324468,"about_ca_topic_score_gemma":3.245661e-7,"domain_scores_codex":[0.9968104,0.0002270896,0.0007108338,0.0008515824,0.0008738487,0.000526209],"domain_scores_gemma":[0.997273,0.000806378,0.000285667,0.0004527836,0.0002033419,0.0009787935],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001304421,0.00006318469,0.000003042648,0.01120763,0.00007483447,0.00001334891,0.000146655,0.000001312599,0.000004959814,0.008891506,0.001624044,0.9778391],"study_design_scores_gemma":[0.000466147,0.0002736605,0.0003348594,0.01374284,0.00001983733,0.00003208842,0.00003909793,0.0001306315,0.000006411544,0.001913578,0.9826828,0.0003580021],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001830349,0.992791,0.00001852791,0.003462073,0.0004554059,0.002605542,0.0001895931,0.00008290301,0.0003766836],"genre_scores_gemma":[0.00001700641,0.9919277,0.00106392,0.002085255,0.002138614,0.001146874,0.001037143,0.0001128356,0.0004706891],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9810588,"threshold_uncertainty_score":0.9997901,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079671777","doi":"10.1517/13543784.12.9.1471","title":"C-peptide and diabetic neuropathy","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Medical Research Council; Diabetes Canada; National Institutes of Health; Canadian Diabetes Association; American Diabetes Association","keywords":"Medicine; Diabetes mellitus; Insulin; Diabetic neuropathy; Type 2 diabetes; Internal medicine; Type 1 diabetes; Endocrinology; Animal studies; Bioinformatics; Biology","authors":[{"name":"Anders A. F. Sima","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05283565834488665,"gpt":0.3660591950859705,"spread":0.3132235367410838,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002211349,0.0003578921,0.000425981,0.0001366843,0.000135813,0.0000398814,0.0002331464,0.0002307169,0.00004622549],"category_scores_gemma":[0.0004876255,0.0003222176,0.0001273145,0.0001965961,0.0002666335,0.00000686787,0.0001164312,0.0002847471,0.0001043879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000376844,"about_ca_system_score_gemma":0.0004022398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001617105,"about_ca_topic_score_gemma":7.921154e-8,"domain_scores_codex":[0.9978737,0.0003671089,0.0003783567,0.000769205,0.0003470171,0.0002646057],"domain_scores_gemma":[0.9989026,0.00009351269,0.0001722971,0.0005055768,0.0001036997,0.0002223374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001626512,0.0001017616,0.000005462998,0.001896999,0.0001176715,0.000002577932,0.0001158043,0.00002854165,0.0003652884,0.009688559,0.0709518,0.9167092],"study_design_scores_gemma":[0.0001356313,0.0001021841,0.000003643469,0.0007674052,0.000004119108,0.00002251699,0.000007984058,0.00000316641,0.0002310549,0.0003473312,0.9980562,0.0003187058],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001162314,0.9964064,0.0000627804,0.0003067623,0.0004763099,0.0004512391,0.00005010505,0.0000172006,0.002217603],"genre_scores_gemma":[0.000006400477,0.9927548,0.001192965,0.001087422,0.0007430925,0.0002436059,0.00142472,0.00007566618,0.002471301],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9271045,"threshold_uncertainty_score":0.999923,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211244827","doi":"10.1517/13543784.11.2.189","title":"The macrolides","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan; St. Paul's Hospital; Royal University Hospital","funders":"","keywords":"Clarithromycin; Azithromycin; Erythromycin; Medicine; Macrolide Antibiotics; Antimicrobial; Antibiotics; Intensive care medicine; Dosing; Adverse effect; Antibiotic resistance; Clinical trial; Pharmacology; Biology; Internal medicine; Microbiology","authors":[{"name":"Glen Hansen","is_ca":true},{"name":"K. Metzler","is_ca":true},{"name":"Emidio DeCarolis","is_ca":true},{"name":"Joseph M. Blondeau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1025710305506434,"gpt":0.3915771278110502,"spread":0.2890060972604068,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000191897,0.0003793967,0.0007048056,0.0001870147,0.0006250226,0.00006949522,0.0001998676,0.0002950107,0.0001898119],"category_scores_gemma":[0.0002798076,0.0002168917,0.0005318286,0.0003438343,0.0003720855,0.00004942972,0.00004444004,0.0006118327,0.00137132],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002018568,"about_ca_system_score_gemma":0.0004861495,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004304439,"about_ca_topic_score_gemma":2.252285e-7,"domain_scores_codex":[0.9980237,0.0001897456,0.0005853836,0.0003769146,0.0005461519,0.0002780406],"domain_scores_gemma":[0.9982404,0.0006545871,0.000242639,0.0004906706,0.00009599046,0.0002757058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000003334093,0.00008637416,0.000003415925,0.0007864106,0.0001838342,0.000005258868,0.0001404031,0.000001273219,0.000002619235,0.01686598,0.1372622,0.8446589],"study_design_scores_gemma":[0.0001753007,0.00008875007,0.00001067689,0.006180749,0.00002685201,0.0001374286,0.00001771713,0.00001429124,0.000002846959,0.0002908758,0.9928346,0.0002199485],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[7.380111e-7,0.980284,0.00000270778,0.005046309,0.001706281,0.0006338014,0.00002960325,0.000111575,0.01218496],"genre_scores_gemma":[0.000002015711,0.9901853,0.00004037301,0.003352636,0.001959003,0.0005066166,0.0002020218,0.00005949304,0.003692538],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8555723,"threshold_uncertainty_score":0.9994062,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2056360850","doi":"10.1517/13543780802528609","title":"Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancer","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Clusterin; Prostate cancer; Cancer; Medicine; Clinical trial; Cancer research; Internal medicine; Oncology; Biology; Apoptosis; Biochemistry","authors":[{"name":"Kim N.","is_ca":true},{"name":"Amina Zoubeidi","is_ca":true},{"name":"Martin Gleave","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1531090493367765,"gpt":0.425771464691668,"spread":0.2726624153548915,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0000976335,0.0004471607,0.00144537,0.0002467363,0.0001172954,0.00000794254,0.0001441771,0.0002988234,0.000228029],"category_scores_gemma":[0.0001471628,0.0002707005,0.0007080409,0.0002358169,0.0004707518,0.0000409962,0.00004028579,0.0001255189,0.00001327006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003652848,"about_ca_system_score_gemma":0.00133844,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006842179,"about_ca_topic_score_gemma":0.00001146982,"domain_scores_codex":[0.9976133,0.0001784773,0.001066551,0.0004895631,0.0004344108,0.0002177016],"domain_scores_gemma":[0.9975355,0.0007702848,0.0007269638,0.0005484914,0.0002565969,0.0001622175],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000351457,0.001002923,0.0000242841,0.008553217,0.0009962581,0.00001017832,0.00271815,0.0001060109,0.0006164716,0.000893315,0.06611922,0.9186085],"study_design_scores_gemma":[0.001443456,0.000762563,0.00005689886,0.005010927,0.0001424237,0.00007642354,0.0000399573,0.0004212456,0.0009412726,0.00001971639,0.9908547,0.0002304541],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005977763,0.9921417,0.00003563927,0.0009405992,0.001883693,0.00298471,0.001279314,0.00002668409,0.0001098927],"genre_scores_gemma":[0.0001170294,0.9910029,0.0009491679,0.0003782258,0.002432142,0.002393828,0.001886738,0.00007502428,0.0007649895],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9247354,"threshold_uncertainty_score":0.9999745,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129376177","doi":"10.1517/13543784.2014.998334","title":"Novel investigational drugs targeting IL-6 signaling for the treatment of depression","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Major depressive disorder; Antidepressant; Signal transduction; Neuroscience; Drug development; Medicine; Function (biology); Bioinformatics; Pharmacology; Drug; Psychology; Biology; Psychiatry; Cognition; Anxiety; Cell biology","authors":[{"name":"Trehani M. Fonseka","is_ca":true},{"name":"Roger S. McIntyre","is_ca":true},{"name":"Joanna K. Soczynska","is_ca":true},{"name":"Sidney H. Kennedy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1507266465870713,"gpt":0.3748199668094526,"spread":0.2240933202223812,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004830438,0.000653966,0.0009688915,0.0002661726,0.0005022134,0.00008749402,0.0006626263,0.0003063751,0.00006341342],"category_scores_gemma":[0.00130447,0.0004272365,0.0007457358,0.000518269,0.0006365072,0.000189684,0.00007403452,0.0002473862,0.00004261725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003091233,"about_ca_system_score_gemma":0.001198486,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002737513,"about_ca_topic_score_gemma":2.689886e-7,"domain_scores_codex":[0.9961449,0.0003010033,0.00105607,0.0009324346,0.001156493,0.0004091111],"domain_scores_gemma":[0.9937524,0.004402179,0.0009066635,0.0004600268,0.0001910773,0.0002876224],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001134813,0.001170807,0.000003150624,0.002258647,0.0002402536,0.000001234543,0.00794488,0.00154479,0.004256363,0.05423177,0.05587293,0.8723617],"study_design_scores_gemma":[0.0009397917,0.0001817474,0.000001362883,0.00263908,0.00002457171,0.000008326073,0.0002088173,0.0007663625,0.005282156,0.002508902,0.9869906,0.0004482626],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004515954,0.9931707,0.0005360561,0.0009648426,0.001670346,0.002278221,0.0007602011,0.0001038565,0.0004706328],"genre_scores_gemma":[0.0001166205,0.990186,0.004020354,0.00117133,0.00149251,0.001616703,0.0009549974,0.0001196951,0.0003217631],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9311177,"threshold_uncertainty_score":0.999818,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1993494094","doi":"10.1517/13543784.16.10.1627","title":"Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"The Scarborough Hospital; University of Toronto; University of Prince Edward Island","funders":"","keywords":"Eicosapentaenoic acid; Clinical trial; Schizophrenia (object-oriented programming); Disease; Medicine; Depression (economics); Neuroprotection; Omega 3 fatty acid; Psychiatry; Placebo; Polyunsaturated fatty acid; Internal medicine; Docosahexaenoic acid; Fatty acid; Biology; Alternative medicine; Pathology; Biochemistry","authors":[{"name":"Cai Song","is_ca":true},{"name":"Shannon X. Zhao","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2169775897946894,"gpt":0.4945456739486987,"spread":0.2775680841540094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001018073,0.0008320408,0.002674809,0.0006406368,0.0004620354,0.00007169264,0.0004488929,0.0004437747,0.00007037439],"category_scores_gemma":[0.002196029,0.0006561935,0.00113222,0.0009772597,0.0006482539,0.0002243806,0.00009029474,0.0006574646,0.00005856452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004163343,"about_ca_system_score_gemma":0.00364069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008166923,"about_ca_topic_score_gemma":0.00001035871,"domain_scores_codex":[0.9932404,0.001125643,0.002727323,0.00124785,0.001001412,0.0006573928],"domain_scores_gemma":[0.9940462,0.001965314,0.00133009,0.0007284408,0.0003044981,0.001625487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001921661,0.0005147526,0.00004266336,0.03440264,0.0002068048,0.000001191306,0.0003010131,9.799486e-7,0.000005467267,0.00559085,0.0999348,0.8588067],"study_design_scores_gemma":[0.001751003,0.001703486,0.00008137762,0.04544955,0.0001621234,0.00001274277,0.00002342715,0.00004775788,0.000114261,0.001307403,0.9488345,0.0005123868],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000007555645,0.9820108,0.0003539163,0.009259427,0.002223815,0.00489056,0.001010185,0.00007886055,0.0001649258],"genre_scores_gemma":[0.000002337127,0.9644586,0.01955595,0.007608238,0.00267338,0.001075926,0.004436651,0.0001147219,0.00007416815],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8582943,"threshold_uncertainty_score":0.9995889,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2100771859","doi":"10.1517/13543784.2015.1009629","title":"Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"AOSpine; Ontario Neurotrauma Foundation; European Commission; Acorda Therapeutics; Hadassah Medical Organization; Medtronic","keywords":"Medicine; Clinical trial; Riluzole; Spinal cord injury; Tolerability; Intensive care medicine; Neuroprotection; Pharmacology; Gabapentin; Adverse effect; Spinal cord; Disease; Internal medicine; Amyotrophic lateral sclerosis; Pathology; Alternative medicine","authors":[{"name":"Narihito Nagoshi","is_ca":true},{"name":"Michael G. Fehlings","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7987099318314077,"gpt":0.7059770694690723,"spread":0.09273286236233536,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02217905,0.0005857773,0.005784575,0.0003673082,0.0001299969,0.00001086212,0.000369251,0.0003732323,0.0001263341],"category_scores_gemma":[0.04376796,0.0003551796,0.001256593,0.0006192171,0.001314043,0.00009154873,0.0001577323,0.0003689747,0.000009302649],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004017579,"about_ca_system_score_gemma":0.006191196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005056382,"about_ca_topic_score_gemma":8.271962e-7,"domain_scores_codex":[0.9863154,0.003681725,0.005782137,0.0008751936,0.003084703,0.0002607988],"domain_scores_gemma":[0.9770662,0.01316131,0.003594231,0.0009882718,0.004567368,0.000622574],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006080949,0.000929579,0.00000894619,0.01297217,0.001558613,1.722422e-7,0.0002987862,7.742445e-7,0.000009476485,0.001156778,0.03026365,0.9467201],"study_design_scores_gemma":[0.004889542,0.03650551,0.00004324268,0.1212288,0.001574179,0.000002977301,0.0001616457,0.0001334671,0.0001414502,0.002156382,0.8329087,0.0002541064],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00134517,0.980908,0.00001824427,0.005232259,0.001083729,0.009748873,0.001599501,0.00001498568,0.00004920156],"genre_scores_gemma":[0.00008513444,0.9872106,0.004800772,0.0009208368,0.001831858,0.003125692,0.001904651,0.00005603594,0.000064375],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.946466,"threshold_uncertainty_score":0.99989,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085430830","doi":"10.1517/13543784.11.12.1795","title":"Novel therapies for sepsis: antiendotoxin therapies","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Health Sciences Centre; Manitoba Health","funders":"","keywords":"Sepsis; Lipopolysaccharide; Immune system; Lipid A; Monoclonal antibody; Immunology; Receptor; Septic shock; Biology; Antibody; Medicine; Internal medicine","authors":[{"name":"Sanjay Manocha","is_ca":true},{"name":"Daniel Feinstein","is_ca":false},{"name":"Aseem Kumar","is_ca":false},{"name":"Anand Kumar","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08159723834029357,"gpt":0.3380841695788234,"spread":0.2564869312385298,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003760321,0.0006128828,0.001111127,0.0004246805,0.0004465531,0.00006115008,0.0004429081,0.0007280853,0.0005691799],"category_scores_gemma":[0.0002002,0.0004817537,0.0006438779,0.0002313598,0.0003669132,0.000193821,0.00005410481,0.0004255876,0.0009652823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001254854,"about_ca_system_score_gemma":0.0002796746,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001315892,"about_ca_topic_score_gemma":2.069776e-7,"domain_scores_codex":[0.9976003,0.0003972384,0.0008788738,0.0005734632,0.000130991,0.0004191614],"domain_scores_gemma":[0.9977437,0.001076236,0.0005524321,0.0004507977,0.0001390659,0.00003782222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008951822,0.0002190606,3.77326e-7,0.001051255,0.001083329,2.77137e-7,0.003350179,0.000001972948,0.002651657,0.03211194,0.09308983,0.8663506],"study_design_scores_gemma":[0.0008699226,0.0001678948,0.00000330539,0.004099541,0.00002543301,0.00002640555,0.000178659,0.000005251959,0.00127835,0.0003886604,0.9924306,0.0005259367],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008298737,0.9938639,0.0002087808,0.001110869,0.002540842,0.001342857,0.0002007547,0.0001411104,0.0005826156],"genre_scores_gemma":[0.00001319494,0.9893602,0.0007059816,0.0007918718,0.0004491704,0.001436496,0.003572836,0.0000890833,0.003581162],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8993408,"threshold_uncertainty_score":0.9998126,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107217435","doi":"10.1517/13543784.14.9.1129","title":"The therapeutic potential of NS3 protease inhibitors in HCV infection","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Hepatitis C virus research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"NS3; Protease; Hepatitis C virus; Virology; Viral replication; Hepatitis C; Medicine; Drug discovery; Biology; Virus; Enzyme; Immunology; Bioinformatics; Biochemistry","authors":[{"name":"Nathalie Goudreau","is_ca":true},{"name":"Montse Llinàs‐Brunet","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08782441455950177,"gpt":0.4167827363426397,"spread":0.3289583217831379,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000788377,0.0003673413,0.0008357921,0.0005643636,0.0001617627,0.0000405464,0.0002064523,0.0003658593,0.0001145375],"category_scores_gemma":[0.0005578964,0.000249308,0.0003838278,0.0006998676,0.0004270973,0.0001097064,0.00007581521,0.0009027375,0.0001688891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005262378,"about_ca_system_score_gemma":0.00178915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002834618,"about_ca_topic_score_gemma":0.00001215917,"domain_scores_codex":[0.9962933,0.0006301118,0.00104426,0.0004386617,0.001249478,0.0003441728],"domain_scores_gemma":[0.9983338,0.0004184914,0.0003704175,0.0004598374,0.0001908197,0.000226662],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003685339,0.000150157,0.00005742123,0.001040116,0.00007562438,0.000003101239,0.0001673383,0.00001046761,0.000007585375,0.001981443,0.003745344,0.9927245],"study_design_scores_gemma":[0.0004980442,0.0001680961,0.0001866087,0.009533659,0.00001414084,0.00001018108,0.00001349539,0.0001561171,0.00003818704,0.0002452019,0.988935,0.0002012491],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004796661,0.9927732,0.00001126939,0.001955453,0.0007058075,0.002481441,0.00002960497,0.00004164234,0.001953623],"genre_scores_gemma":[0.0005141898,0.9958369,0.0001270672,0.0003483423,0.0014228,0.001024979,0.0003603568,0.00006895565,0.0002963877],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9925233,"threshold_uncertainty_score":0.9999959,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2000370942","doi":"10.1517/13543784.9.9.2051","title":"Animal models in xenotransplantation","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Xenotransplantation and immune response","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"London Health Sciences Centre","funders":"Medical Research Council; Physicians' Services Incorporated Foundation","keywords":"Xenotransplantation; Biology; Animal model; Computational biology; Transplantation; Medicine; Internal medicine; Endocrinology","authors":[{"name":"Zheng Zhang","is_ca":true},{"name":"Eric L.R. Bédard","is_ca":true},{"name":"Yigang Luo","is_ca":true},{"name":"Hao Wang","is_ca":true},{"name":"Shaoping Deng","is_ca":true},{"name":"David J. Kelvin","is_ca":true},{"name":"Robert Zhong","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09810914091250716,"gpt":0.3836695085772858,"spread":0.2855603676647786,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002658814,0.0005188962,0.001183544,0.0007728664,0.00008780126,0.0000357386,0.000176431,0.0004433009,0.0005019549],"category_scores_gemma":[0.00003531518,0.0004564827,0.0003894981,0.000556024,0.000139037,0.0002196528,0.000009631313,0.000645643,0.0004943697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002701031,"about_ca_system_score_gemma":0.001098149,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004604588,"about_ca_topic_score_gemma":8.78517e-7,"domain_scores_codex":[0.9970217,0.000347811,0.001014849,0.0005957028,0.0006922422,0.0003277426],"domain_scores_gemma":[0.9987944,0.0003838137,0.0001970767,0.0003275768,0.00005526901,0.0002418304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001806267,0.0006139648,0.000004236057,0.008642924,0.0002274177,0.00008961998,0.004150991,0.0002279002,0.00002955325,0.0402645,0.004911303,0.9390313],"study_design_scores_gemma":[0.001268459,0.0002127705,0.00005311845,0.02539179,0.00003904877,0.0001737841,0.00003992748,0.0003970142,0.00002481522,0.0005493318,0.9714026,0.0004473744],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004455794,0.9885048,0.00003912138,0.0007029649,0.0003077163,0.001065277,0.0001511814,0.0001045582,0.00907982],"genre_scores_gemma":[0.0001136067,0.9915829,0.0006108765,0.001477436,0.0003379245,0.000330595,0.004961248,0.00008866508,0.0004967239],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9664913,"threshold_uncertainty_score":0.9997887,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1897302030","doi":"10.1517/13543784.2015.1051220","title":"Targeting of cancer stem cells by inhibitors of DNA and histone methylation","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"China Scholarship Council","keywords":"Histone; DNA methylation; Epigenetics; Cancer; Biology; Cancer research; Cancer epigenetics; Cancer stem cell; Stem cell; DNA; Genetics; Histone methyltransferase; Computational biology; Gene; Gene expression","authors":[{"name":"Richard L. Momparler","is_ca":true},{"name":"Sylvie Côté","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04232140536129853,"gpt":0.3578750581984829,"spread":0.3155536528371844,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004075282,0.0002624769,0.000579398,0.0001093617,0.00004208295,0.000008318583,0.0001224621,0.0003345551,0.000008627576],"category_scores_gemma":[0.00005190377,0.000240784,0.0001296914,0.000131863,0.0002139867,0.000005870799,0.00007063229,0.0001091838,0.00000151127],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005736344,"about_ca_system_score_gemma":0.0003629628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005867912,"about_ca_topic_score_gemma":6.120483e-7,"domain_scores_codex":[0.9982231,0.0002057126,0.0007062614,0.0003824296,0.0003581923,0.0001243369],"domain_scores_gemma":[0.9986408,0.00006237811,0.0007564981,0.0001980814,0.0002251563,0.0001171047],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002882535,0.0001111079,0.00002342358,0.002901022,0.0002167664,1.133171e-7,0.0005948565,0.000216164,0.2985822,0.0005623191,0.02626639,0.6704968],"study_design_scores_gemma":[0.0001541873,0.00009883266,0.000001037212,0.001016758,0.00001483325,1.375696e-7,0.00002598351,0.00002297131,0.1956015,0.00009561131,0.8027778,0.0001903766],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001340543,0.997252,0.00008102204,0.00005241336,0.0005822086,0.0003309197,0.0002390266,0.000005086658,0.0001167155],"genre_scores_gemma":[0.0006260358,0.9967802,0.0004733342,0.00003216281,0.0003969136,0.00007218053,0.001418363,0.00004007157,0.0001607105],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7765114,"threshold_uncertainty_score":0.9818888,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122631980","doi":"10.1517/13543784.11.11.1605","title":"Selective phosphodiesterase type 5 inhibition using tadalafil for the treatment of erectile dysfunction","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Centre","funders":"","keywords":"Tadalafil; Erectile dysfunction; Sildenafil; Medicine; cGMP-specific phosphodiesterase type 5; Broad spectrum; Placebo; Population; Pharmacotherapy; Pharmacology; Internal medicine; Alternative medicine; Chemistry; Pathology","authors":[{"name":"James K. Kuan","is_ca":true},{"name":"Gerald Brock","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.211736959062446,"gpt":0.4044957225534691,"spread":0.1927587634910231,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001441533,0.0004829396,0.001081459,0.0002912328,0.0004042302,0.00002602443,0.00005007047,0.00026058,0.0002620077],"category_scores_gemma":[0.0002661587,0.000307958,0.0004998595,0.0006145606,0.000210118,0.00008626212,0.00001492691,0.0001860325,0.00006908366],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007678582,"about_ca_system_score_gemma":0.0004207092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007900925,"about_ca_topic_score_gemma":0.000001168913,"domain_scores_codex":[0.9979388,0.0001207548,0.000725898,0.00051475,0.0004764578,0.0002233984],"domain_scores_gemma":[0.9973864,0.001118912,0.0004920451,0.0003272854,0.0005426997,0.0001326852],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008880546,0.001351591,0.00002415513,0.002636129,0.001916343,0.00000168935,0.002885744,0.0001610677,0.000041084,0.00254703,0.1277353,0.8598118],"study_design_scores_gemma":[0.001334586,0.001793813,0.00001686915,0.002776595,0.0002353644,0.00003637943,0.0002837992,0.0004502722,0.0001840191,0.00005302215,0.9925836,0.0002516547],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003960928,0.9916646,0.0004125956,0.0003625725,0.004327735,0.002264937,0.0001091931,0.00008413709,0.0007346409],"genre_scores_gemma":[0.00003384723,0.9928761,0.0005557368,0.000653381,0.0018209,0.0008488119,0.000868257,0.00006915389,0.002273859],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8648484,"threshold_uncertainty_score":0.9999372,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168406738","doi":"10.1517/13543784.10.12.2157","title":"Therapeutic potential of mycobacterial cell wall-DNA complexes","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Cell wall; Cell; Effector; Apoptosis; Biology; DNA; Cell division; Immune system; Mechanism of action; Cell growth; Mycobacterium; Cancer cell; Mycobacterium phlei; Cancer research; Microbiology; Cancer; Chemistry; Cell biology; Bacteria; Immunology; In vitro; Biochemistry; Genetics","authors":[{"name":"Nigel C. Phillips","is_ca":true},{"name":"Mario Filion","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07827342594698494,"gpt":0.3700735214891212,"spread":0.2918000955421363,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002783237,0.0005709117,0.001652693,0.0004525578,0.0001211406,0.00005595961,0.0003544024,0.0004276599,0.001915392],"category_scores_gemma":[0.0001593451,0.0004488875,0.0007359505,0.0004529821,0.0003536779,0.000106589,0.00009946011,0.0005006432,0.0003802105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002115383,"about_ca_system_score_gemma":0.001258192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007473565,"about_ca_topic_score_gemma":3.687029e-7,"domain_scores_codex":[0.9963151,0.0003629733,0.001018139,0.0006244141,0.001212278,0.0004670602],"domain_scores_gemma":[0.9976483,0.0005149469,0.0004814759,0.0005691391,0.0002477536,0.000538401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008978327,0.002673647,0.0001150343,0.02713236,0.001281231,0.00006991678,0.000802706,0.000005072949,0.003691964,0.01006558,0.1761342,0.7771304],"study_design_scores_gemma":[0.001054399,0.0004731526,0.0001630528,0.008354465,0.00006934414,0.00004886623,0.00002328781,0.00001369558,0.000417853,0.0002598214,0.9887537,0.000368308],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002681503,0.9935311,0.00001297421,0.0009224802,0.001253669,0.001257454,0.0002859346,0.00007326166,0.002394987],"genre_scores_gemma":[0.0002626718,0.9905776,0.0003929535,0.001058274,0.002326024,0.000313449,0.004548681,0.00009309108,0.0004272816],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8126195,"threshold_uncertainty_score":0.9997963,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230784343","doi":"10.1517/13543784.14.7.905","title":"Stiripentol","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Dravet syndrome; Medicine; Carbamazepine; Epilepsy; Felbamate; CYP2C19; Tolerability; Clobazam; Pharmacology; Myoclonic epilepsy; Orphan drug; Adjunctive treatment; Clinical trial; Pediatrics; Adverse effect; Internal medicine; Bioinformatics; Psychiatry","authors":[{"name":"Catherine Chiron","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1348169047952925,"gpt":0.4447422447116589,"spread":0.3099253399163664,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001893046,0.0004834388,0.001129193,0.0003717727,0.0001309477,0.00004270835,0.0001899557,0.0002910231,0.001026262],"category_scores_gemma":[0.0002211516,0.0003506531,0.0005356738,0.0003091277,0.0001976222,0.00007694261,0.00006164113,0.000563885,0.003102626],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005450504,"about_ca_system_score_gemma":0.001449735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001705623,"about_ca_topic_score_gemma":3.995879e-7,"domain_scores_codex":[0.9971887,0.0001653372,0.0005975849,0.0005975952,0.001063397,0.0003873545],"domain_scores_gemma":[0.9981655,0.0003423677,0.0001883471,0.0005138976,0.0001127504,0.0006771102],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001953717,0.0002627527,0.000006089483,0.001110793,0.0002238172,0.00001543389,0.00008793945,4.653758e-7,1.878985e-7,0.006664738,0.09344421,0.898164],"study_design_scores_gemma":[0.0006509213,0.0002674029,0.00002002751,0.01330515,0.00003104754,0.0000684055,0.00001219,0.00001187439,0.000004735593,0.0001503354,0.9852111,0.0002668299],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[8.190287e-7,0.9819657,0.000004289154,0.002763856,0.0004595782,0.001224685,0.00008369398,0.000101292,0.01339605],"genre_scores_gemma":[0.000002552695,0.9865295,0.001402707,0.001464212,0.002388705,0.0007686593,0.003373912,0.00007552181,0.003994241],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8978972,"threshold_uncertainty_score":0.9998946,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132420892","doi":"10.1517/13543784.17.5.619","title":"Osteoarthritic pain: a review of current, theoretical and emerging therapeutics","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Chronic pain; Tolerability; Intensive care medicine; Osteoarthritis; Clinical trial; Population; Etiology; Bioinformatics; Alternative medicine; Physical therapy; Psychiatry; Pathology; Biology","authors":[{"name":"Simon Read","is_ca":false},{"name":"Andy Dray","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06397579900833963,"gpt":0.3767876863065986,"spread":0.3128118872982589,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003311115,0.0004714212,0.001492053,0.0002030458,0.0001015599,0.00001037969,0.0001075133,0.0002015317,0.0001563158],"category_scores_gemma":[0.0003383256,0.0003627037,0.0004374123,0.0002513477,0.0005504444,0.00005331368,0.00004955228,0.0003685752,0.00003867867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007308769,"about_ca_system_score_gemma":0.0006553063,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":5.572311e-7,"about_ca_topic_score_gemma":4.624272e-8,"domain_scores_codex":[0.9974278,0.0004069409,0.0008257185,0.0004618542,0.0006302107,0.0002475095],"domain_scores_gemma":[0.9982756,0.0006523276,0.0003179445,0.0003565669,0.0001452596,0.0002523217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000008927926,0.00009765739,0.000001079529,0.02223002,0.00005710425,0.00000491223,0.0001567041,5.926431e-9,0.000001707038,0.06262047,0.002129873,0.9126915],"study_design_scores_gemma":[0.000543775,0.0005545113,3.13613e-7,0.2753322,0.0000662451,0.0001049931,0.00001370845,0.000002635608,0.00001220299,0.0007742984,0.7223873,0.0002079285],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00000342042,0.9961975,0.00001264823,0.0009936726,0.0005175002,0.001297772,0.00005771889,0.0000472934,0.0008725146],"genre_scores_gemma":[0.000006421878,0.9943579,0.0005166045,0.00304023,0.0004744468,0.000304658,0.001192327,0.00006546122,0.00004188519],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9124836,"threshold_uncertainty_score":0.9998825,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2299867389","doi":"10.1517/13543784.2016.1142529","title":"Novel investigational therapies for onychomycosis: an update","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Terbinafine; Dermatology; Adverse effect; Azole; Pharmacology; Drug; Clinical trial; Investigational Drugs; Antifungal; Internal medicine; Itraconazole","authors":[{"name":"Aditya Gupta","is_ca":true},{"name":"Catherine Studholme","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1158912842742081,"gpt":0.4118034750595802,"spread":0.2959121907853721,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000200928,0.0007232513,0.001223126,0.0003738182,0.0002740593,0.00007651852,0.0002777429,0.0003697029,0.0003977976],"category_scores_gemma":[0.0002257495,0.000489728,0.0007369532,0.0002442097,0.0003319,0.0002706321,0.00004536249,0.000222647,0.0003573589],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003642518,"about_ca_system_score_gemma":0.001663077,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001228085,"about_ca_topic_score_gemma":3.901865e-7,"domain_scores_codex":[0.9969265,0.0001156719,0.0008246667,0.0009201952,0.0008119518,0.0004010469],"domain_scores_gemma":[0.9974347,0.0004631705,0.0004639797,0.0006135085,0.0002689358,0.0007556975],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001320194,0.0009399711,0.00002716226,0.002323949,0.001142204,0.000002571257,0.0002375595,7.781554e-7,0.00001169791,0.1023072,0.04366364,0.8492112],"study_design_scores_gemma":[0.002087037,0.000338327,0.0001419819,0.01615289,0.0001141715,0.00003042798,0.00002234539,0.00001590888,0.00001162345,0.005438784,0.9751424,0.0005041264],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000009930474,0.9904326,0.0002213451,0.003618027,0.000992448,0.002113281,0.001989902,0.0001530763,0.0004693494],"genre_scores_gemma":[0.00001382022,0.9702139,0.007887541,0.004580967,0.002365747,0.00275166,0.01128986,0.0001579399,0.0007385383],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9314787,"threshold_uncertainty_score":0.9997554,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095646768","doi":"10.1517/13543784.12.10.1655","title":"Targeting cellular energy production in neurological disorders","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Coenzyme Q10 studies and effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Coenzyme Q10; Neuroprotection; Oxidative stress; Ataxia; Medicine; Amyotrophic lateral sclerosis; Creatine; Neuroscience; Disease; Excitotoxicity; Mitochondrial disease; Bioinformatics; Pharmacology; Biology; Pathology; Internal medicine; Biochemistry; Glutamate receptor","authors":[{"name":"Steven K. Baker","is_ca":true},{"name":"Mark A. Tarnopolsky","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02458881649965107,"gpt":0.2946587498849035,"spread":0.2700699333852525,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002392454,0.0003998349,0.0005113813,0.0001187479,0.0001331554,0.00001952723,0.0001846742,0.000346161,0.00001905627],"category_scores_gemma":[0.000302646,0.0003446417,0.0002277835,0.0002302957,0.0001351858,0.000004373851,0.0001059311,0.0002441533,0.00001725816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003218394,"about_ca_system_score_gemma":0.0001555109,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002421145,"about_ca_topic_score_gemma":0.000004212944,"domain_scores_codex":[0.9978096,0.000405009,0.0004453914,0.0007889571,0.0002489323,0.0003021015],"domain_scores_gemma":[0.9993432,0.00005984211,0.0001873025,0.0002777575,0.00003579798,0.00009616855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000629336,0.0004350278,0.0000535641,0.001442555,0.0001785897,0.000005461693,0.0001772788,0.0006991712,0.0005796261,0.005808535,0.642805,0.3477523],"study_design_scores_gemma":[0.0001381708,0.0001528855,0.00000387709,0.0005727377,0.000004233319,0.000003656588,0.00001318177,0.0000241891,0.0001297184,0.0001720174,0.9984373,0.0003480653],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006709907,0.9971924,0.00003852009,0.0004604653,0.001529757,0.0003404374,0.000009576211,0.00001680508,0.0003449499],"genre_scores_gemma":[0.0001532595,0.995528,0.0001650964,0.000762575,0.001281631,0.0003851177,0.00141132,0.00004888747,0.0002640875],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3556323,"threshold_uncertainty_score":0.9999006,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047633734","doi":"10.1517/13543784.17.7.1029","title":"Heparin as an anticancer therapeutic","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Heparin; Pharmacology; Intensive care medicine; Medicine; Anticancer drug; Drug; Internal medicine","authors":[{"name":"Leo R. Zacharski","is_ca":false},{"name":"Agnes YY Lee","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07779585488762812,"gpt":0.4086712590680824,"spread":0.3308754041804542,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001710989,0.0005240389,0.0006548263,0.0001858203,0.0002474935,0.00006262983,0.0006390374,0.0005228477,0.0001491201],"category_scores_gemma":[0.0001070845,0.0004411837,0.0003538624,0.0002437055,0.0004131411,0.00001137039,0.0001436551,0.0004095632,0.000256302],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009763207,"about_ca_system_score_gemma":0.001679036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001079897,"about_ca_topic_score_gemma":0.000003235584,"domain_scores_codex":[0.99711,0.0003604235,0.0004891382,0.0009203129,0.0006796537,0.0004404491],"domain_scores_gemma":[0.9984831,0.00005985967,0.0001868581,0.0007737259,0.0001293573,0.0003670905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005993912,0.0001957874,0.000004509764,0.0004123335,0.0002182041,0.000007064446,0.0001323737,0.000007070454,0.0002216845,0.006883292,0.02165824,0.9701995],"study_design_scores_gemma":[0.0002581311,0.0004278598,0.000007877628,0.0009646617,0.000005121226,0.00008248819,0.00001446561,0.00002086939,0.0005640895,0.0003812872,0.9967586,0.0005145271],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006920949,0.9953083,0.00004798048,0.0002603779,0.0004755303,0.0007244261,0.00009764112,0.00003097399,0.002985503],"genre_scores_gemma":[0.00008782826,0.9909405,0.0003771345,0.001575739,0.001729631,0.0006184388,0.003320496,0.0001006952,0.001249585],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9751004,"threshold_uncertainty_score":0.999804,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130413670","doi":"10.1517/13543784.9.5.1099","title":"Pharmacology and clinical assessment of cariporide for the treatment coronary artery diseases","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Medicine; Myocardial infarction; Cardiology; Internal medicine; Clinical trial; Placebo; Coronary artery disease; Thrombolysis; Pharmacology","authors":[{"name":"Morris Karmazyn","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07327883999910648,"gpt":0.4473595719300431,"spread":0.3740807319309366,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001876905,0.0003215991,0.001224624,0.0000926061,0.0001390209,0.000009398586,0.00008227111,0.0002418109,0.0001158676],"category_scores_gemma":[0.00003881252,0.0001801161,0.0008436638,0.00008245579,0.0004129825,0.0000264936,0.0000282242,0.0002185595,0.000004772735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001877241,"about_ca_system_score_gemma":0.001243757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009769271,"about_ca_topic_score_gemma":1.109996e-7,"domain_scores_codex":[0.9981641,0.0001684443,0.0007563758,0.0004340818,0.0003168375,0.000160128],"domain_scores_gemma":[0.9970439,0.002122613,0.000268777,0.0002734953,0.00006913509,0.0002220521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001375473,0.0005699114,0.0002245245,0.00117901,0.001067688,0.000006005399,0.0001078592,0.000003253682,0.00000702938,0.0004747527,0.03614534,0.960077],"study_design_scores_gemma":[0.001506437,0.000750007,0.0005748594,0.002489252,0.0006613461,0.0000662045,0.00002760538,0.0001230572,0.00001726483,0.00003450569,0.9935873,0.0001621745],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004175001,0.9936278,0.000007609282,0.00137099,0.001881169,0.002059719,0.0002930088,0.00002328377,0.0003188529],"genre_scores_gemma":[0.00009278528,0.9935357,0.0003211746,0.0007912875,0.00231881,0.0008697748,0.001698676,0.00003602778,0.0003357605],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9599149,"threshold_uncertainty_score":0.734492,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2057495794","doi":"10.1517/13543784.2011.565329","title":"Brivanib alaninate for cancer","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cetuximab; Medicine; Pharmacodynamics; Pharmacology; Cancer; Regorafenib; Angiogenesis; Colorectal cancer; Pharmacokinetics; Oncology; Internal medicine","authors":[{"name":"Iván Díaz-Padilla","is_ca":true},{"name":"Lillian L. Siu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1165598438133721,"gpt":0.4131320326980932,"spread":0.2965721888847211,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001889802,0.0004284642,0.00055224,0.000143037,0.0001267701,0.00003612833,0.0004976683,0.0004538141,0.0001343187],"category_scores_gemma":[0.0002063354,0.0003751281,0.0003988579,0.0001295654,0.0001890839,0.000005784905,0.0001563957,0.0002365163,0.0001113073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008424473,"about_ca_system_score_gemma":0.0009522178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004504685,"about_ca_topic_score_gemma":0.000002480983,"domain_scores_codex":[0.9980317,0.0001434094,0.0004256083,0.0007266381,0.0002943123,0.0003782898],"domain_scores_gemma":[0.9988444,0.00009412225,0.0002239979,0.0004456502,0.0001656401,0.0002262139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009726823,0.0001317251,0.00000697664,0.004495202,0.0004972711,7.657333e-7,0.0001964795,0.000005666738,0.0008472179,0.01915151,0.3313421,0.6432278],"study_design_scores_gemma":[0.00023802,0.0001940899,0.000004187026,0.0026444,0.000007412995,0.000004794415,0.000005072317,0.000005943354,0.001134722,0.0002970216,0.995056,0.0004083887],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008168098,0.9964209,0.00007750361,0.0001801827,0.0008223057,0.0009777214,0.0005110877,0.00002454298,0.0009775634],"genre_scores_gemma":[0.000006702943,0.9893199,0.0008278825,0.0005138509,0.001672288,0.001639253,0.004122655,0.0001207677,0.00177674],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6637138,"threshold_uncertainty_score":0.9998701,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2287387906","doi":"10.1517/13543784.2015.1083010","title":"An evaluation of RVX-208 for the treatment of atherosclerosis","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Calgary","funders":"","keywords":"Bromodomain; Apolipoprotein B; Mechanism (biology); Epigenetics; Pharmacology; Reverse cholesterol transport; Lipoprotein; Mechanism of action; Drug; Medicine; Cholesterol; Bioinformatics; Biology; Internal medicine; In vitro; Biochemistry; Gene","authors":[{"name":"Dragana Nikolić","is_ca":false},{"name":"Manfredi Rizzo","is_ca":false},{"name":"Dimitri P. Mikhailidis","is_ca":false},{"name":"Norman C.W. Wong","is_ca":true},{"name":"Maciej Banach","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.19381988199037,"gpt":0.4284758641484715,"spread":0.2346559821581015,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000599248,0.0002273233,0.000409424,0.00006604895,0.00006427087,0.00001067119,0.0002148408,0.0002137254,0.00001954611],"category_scores_gemma":[0.0001440452,0.0001478354,0.0002904196,0.00009882129,0.0001600781,0.000005682076,0.00001382745,0.00003658774,0.000003255521],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009082293,"about_ca_system_score_gemma":0.0007659937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001639645,"about_ca_topic_score_gemma":9.52351e-7,"domain_scores_codex":[0.9983545,0.0002717183,0.0004731266,0.0003022212,0.0004989252,0.00009953138],"domain_scores_gemma":[0.9984827,0.00007974157,0.0004465632,0.0004553498,0.0004573986,0.0000782471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003042174,0.0003537177,0.000002898454,0.0002689791,0.0001984236,4.571079e-9,0.0003658702,0.0001041707,0.001089875,0.001730847,0.01029779,0.985557],"study_design_scores_gemma":[0.0005461363,0.0008934524,0.000005703225,0.0005640051,0.00004895088,4.664973e-7,0.00005031512,0.0002511632,0.01043664,0.0001837455,0.9868758,0.0001436744],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001940673,0.9970714,0.0001251712,0.0001174505,0.0005179304,0.001581947,0.000270835,0.000005827616,0.0001153428],"genre_scores_gemma":[0.0002413161,0.9932352,0.0007726843,0.00007621524,0.000721328,0.001231651,0.003607638,0.00003248818,0.00008142603],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9854133,"threshold_uncertainty_score":0.6028551,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2416001425","doi":"10.1080/13543784.2016.1195808","title":"Investigational targeted therapies for the treatment of testicular germ cell tumors","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Brentuximab vedotin; Clinical trial; Oncology; Internal medicine; Targeted therapy; Germ cell tumors; Sunitinib; Disease; Ifosfamide; Chemotherapy; Cancer; Lymphoma; Etoposide; Hodgkin lymphoma","authors":[{"name":"Christoph Oing","is_ca":false},{"name":"Christian Kollmannsberger","is_ca":true},{"name":"Karin Oechsle","is_ca":false},{"name":"Carsten Bokemeyer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06552153533269944,"gpt":0.360707653935143,"spread":0.2951861186024436,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001281281,0.0006639577,0.001239538,0.0002106997,0.0002335846,0.00002939959,0.0002052468,0.0002184062,0.0002134365],"category_scores_gemma":[0.0003596957,0.0003352322,0.001050787,0.000248965,0.0005178817,0.00006015823,0.00002250084,0.0001070428,0.0001063624],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003775958,"about_ca_system_score_gemma":0.001741124,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002574177,"about_ca_topic_score_gemma":1.552786e-7,"domain_scores_codex":[0.9973716,0.0001482016,0.0008508406,0.0005922465,0.0007230199,0.0003140794],"domain_scores_gemma":[0.9957351,0.002310206,0.000731145,0.0006035912,0.0002693927,0.0003505542],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001221898,0.002221488,0.0001790601,0.00363071,0.002289015,0.00001225137,0.0008657047,0.00001291691,0.00003137409,0.01511534,0.01224104,0.9632789],"study_design_scores_gemma":[0.001915924,0.0009584618,0.0003314659,0.009005336,0.000325361,0.00002028998,0.00002822877,0.00005598153,0.000170214,0.001365738,0.9854916,0.0003313849],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004817014,0.9937949,0.00006632208,0.001406444,0.0004945256,0.002940078,0.001036408,0.00006722267,0.0001459573],"genre_scores_gemma":[0.0001591646,0.9898189,0.002456855,0.0004844059,0.0009660041,0.00266352,0.002766397,0.0001067172,0.000578074],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9732506,"threshold_uncertainty_score":0.99991,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2160247377","doi":"10.1517/13543784.17.2.217","title":"The use of dexrazoxane for the prevention of anthracycline extravasation injury","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Canada Research Chairs","keywords":"Dexrazoxane; Anthracycline; Cardiotoxicity; Extravasation; Doxorubicin; Epirubicin; Medicine; Daunorubicin; Pharmacology; Idarubicin; Chemotherapy; Internal medicine; Pathology; Cancer; Cyclophosphamide; Breast cancer","authors":[{"name":"Brian B. Hasinoff","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1877064176791583,"gpt":0.419788730279666,"spread":0.2320823126005077,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004372149,0.0003459665,0.0009027494,0.0001704998,0.0002490848,0.00001609776,0.0002548684,0.0003547147,0.000039837],"category_scores_gemma":[0.001193169,0.0001982695,0.0006800198,0.0003853279,0.0006734563,0.0001066345,0.00003618873,0.0003864053,0.000006505753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001520753,"about_ca_system_score_gemma":0.0007933875,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003025974,"about_ca_topic_score_gemma":0.00000115723,"domain_scores_codex":[0.9972169,0.0002294494,0.001295489,0.0003465868,0.0007215408,0.0001899747],"domain_scores_gemma":[0.9941002,0.003592052,0.001225135,0.000650041,0.0003433159,0.00008930323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002382994,0.0002774505,0.000004146843,0.001412465,0.0005316696,2.33574e-7,0.0004696772,0.00003317881,0.0001668746,0.0035591,0.03760974,0.9556972],"study_design_scores_gemma":[0.0006072324,0.0002804777,0.00004994458,0.008869588,0.00007571703,0.00002403194,0.00002061114,0.0003515688,0.001572518,0.0004793638,0.9875025,0.0001664967],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008072577,0.9938475,0.0008081985,0.001660133,0.0006738445,0.00270908,0.000145648,0.00003140793,0.00004340722],"genre_scores_gemma":[0.00007359933,0.9943624,0.002835898,0.0003012198,0.0005630137,0.000391371,0.0008888803,0.00006695224,0.0005166969],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9555306,"threshold_uncertainty_score":0.8085195,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2101906616","doi":"10.1517/13543784.16.10.1525","title":"Next-generation calcineurin inhibitors for ophthalmic indications","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"National Institute for Nanotechnology","funders":"","keywords":"Calcineurin; Ciclosporin; Medicine; Tacrolimus; Pharmacology; Uveitis; Blepharitis; Transplantation; Ophthalmology; Immunology; Internal medicine","authors":[{"name":"Eddy Anglade","is_ca":false},{"name":"Randall W. Yatscoff","is_ca":true},{"name":"Robert T. Foster","is_ca":true},{"name":"Ulrich Grau","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2398880046859435,"gpt":0.4298117209830393,"spread":0.1899237162970958,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003151525,0.0005465062,0.001034928,0.0006577546,0.0002748036,0.00007454386,0.000202639,0.0004897515,0.000248129],"category_scores_gemma":[0.0003179521,0.0004661325,0.0008120092,0.0005154781,0.0001753389,0.0001552665,0.00004803901,0.0003916589,0.0002355267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003868114,"about_ca_system_score_gemma":0.001227609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001785868,"about_ca_topic_score_gemma":4.173616e-7,"domain_scores_codex":[0.9969868,0.0001028556,0.001003289,0.0007722941,0.0007652547,0.0003695118],"domain_scores_gemma":[0.9979974,0.0002943306,0.0004424577,0.000526551,0.0002015779,0.0005376671],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004161163,0.0007827054,0.00002124791,0.00601369,0.0003923754,0.00001656173,0.0002760462,0.000008681088,0.00008187156,0.01582248,0.1280214,0.8485213],"study_design_scores_gemma":[0.0006314553,0.0002531013,0.00003504079,0.006709182,0.000102629,0.000129361,0.00002303169,0.0001131574,0.00005776396,0.0002021416,0.9913055,0.0004376397],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006666084,0.9927359,0.0001396084,0.001790645,0.00173613,0.002530481,0.0002660096,0.0001097505,0.0006248414],"genre_scores_gemma":[0.0001089557,0.9726029,0.002294738,0.001422678,0.004872473,0.00122206,0.01633397,0.0001332077,0.001009019],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8632841,"threshold_uncertainty_score":0.999779,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122461299","doi":"10.1517/13543784.17.5.811","title":"Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"","keywords":"Roflumilast; Medicine; COPD; Asthma; Intensive care medicine; Lung function; Internal medicine; Lung","authors":[{"name":"Stephen K. Field","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04072050588806207,"gpt":0.3306587140258579,"spread":0.2899382081377958,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001412511,0.0002955641,0.000380839,0.0000682547,0.0002270627,0.00002258729,0.0001586562,0.0002327675,0.000007418354],"category_scores_gemma":[0.00002677996,0.0002104621,0.0001863368,0.0001304886,0.0002733008,0.00001076218,0.0000697377,0.0001080303,0.000004175173],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004355473,"about_ca_system_score_gemma":0.0001933887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006931594,"about_ca_topic_score_gemma":0.000001165544,"domain_scores_codex":[0.9986106,0.0001164619,0.000409306,0.0004638793,0.0002475011,0.0001522781],"domain_scores_gemma":[0.9991176,0.00007765433,0.0002817496,0.0002834298,0.0001410181,0.00009855196],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002207324,0.0002380783,0.000005473467,0.00191176,0.00087734,7.845607e-7,0.0005831963,0.0001147736,0.0002994327,0.006949939,0.1549722,0.8338262],"study_design_scores_gemma":[0.0004501058,0.000310785,0.00005306141,0.001164613,0.00001684601,0.00001469077,0.00008416845,0.00007844436,0.0009613765,0.00008506567,0.9965475,0.0002334038],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001344594,0.9969251,0.0004621716,0.000244025,0.0007966925,0.001086244,0.0001142262,0.00001479928,0.00022227],"genre_scores_gemma":[0.0001513309,0.9943839,0.001462027,0.0004203236,0.0006056378,0.0004759365,0.00190895,0.00003999723,0.0005519082],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8415752,"threshold_uncertainty_score":0.8582397,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2997288603","doi":"10.1080/13543784.2020.1709822","title":"Phase I/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation","year":2020,"lang":"en","type":"article","venue":"Expert Opinion on Investigational Drugs","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Etanercept; Medicine; Physical therapy; Placebo; Stroke (engine); Visual analogue scale; Randomized controlled trial; Chronic pain; Clinical trial; Chronic stroke; Physical medicine and rehabilitation; Rehabilitation; Internal medicine; Tumor necrosis factor alpha","authors":[{"name":"Stephen J. Ralph","is_ca":false},{"name":"Andrew Weissenberger","is_ca":false},{"name":"Ventzislav Bonev","is_ca":false},{"name":"Liam King","is_ca":false},{"name":"Mikaela D. Bonham","is_ca":false},{"name":"Samantha Ferguson","is_ca":false},{"name":"Ashley Smith","is_ca":true},{"name":"Adrienne A. Goodman-Jones","is_ca":false},{"name":"Anthony Espinet","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1003967417263509,"gpt":0.3981617017785402,"spread":0.2977649600521893,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002421213,0.0002751361,0.001494722,0.00006895689,0.0001537622,0.0000183323,0.0001043831,0.0003707655,0.0001317807],"category_scores_gemma":[0.003722737,0.0001905443,0.0006968183,0.0001174494,0.0006962757,0.00007772425,0.00004071592,0.0004290486,0.000003587792],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003528977,"about_ca_system_score_gemma":0.0003640455,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000647407,"about_ca_topic_score_gemma":2.791427e-7,"domain_scores_codex":[0.9964858,0.0008046795,0.001490064,0.0005740068,0.0004200608,0.0002254412],"domain_scores_gemma":[0.9966119,0.002115786,0.0005012897,0.0001886012,0.0001849313,0.0003974839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9857993,0.001744324,0.000005351017,0.00006321733,0.0003321893,5.202612e-7,0.0006313794,0.0001112126,0.002525885,0.003585314,0.001070528,0.004130822],"study_design_scores_gemma":[0.8552068,0.01807334,0.0000244908,0.00005029224,0.00005730828,0.000001098853,0.00007339477,0.121144,0.0001923518,0.0005870677,0.00443285,0.0001570143],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8458523,0.002651938,0.008379037,0.1227886,0.00103795,0.01855809,0.00006206299,0.0001551332,0.0005148604],"genre_scores_gemma":[0.9797888,0.003032994,0.002843506,0.01072838,0.001213598,0.001726586,0.0004577699,0.0000333114,0.0001750615],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1339364,"threshold_uncertainty_score":0.7770169,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002307343","doi":"10.1517/13543784.2011.549125","title":"AMG 386: profile of a novel angiopoietin antagonist in patients with ovarian cancer","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation; Amgen (Canada)","funders":"","keywords":"Angiopoietin 2; Ovarian cancer; Medicine; Angiogenesis; Malignancy; Cancer; Oncology; Antagonist; Internal medicine; Disease; Tumor progression; Overall survival; Cancer research; Receptor; VEGF receptors; Vascular endothelial growth factor","authors":[{"name":"Ewan J.D. Robson","is_ca":true},{"name":"Prafull Ghatage","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0426732515451642,"gpt":0.3193840067145453,"spread":0.276710755169381,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001165118,0.0003639456,0.0005844155,0.0001280853,0.00005439119,0.00001197232,0.0002717579,0.000316407,0.0001111351],"category_scores_gemma":[0.00002708114,0.0002831826,0.0002202739,0.0002154259,0.0002081039,0.00000606119,0.00008031088,0.0001274452,0.000007925712],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007297711,"about_ca_system_score_gemma":0.0008348334,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001886145,"about_ca_topic_score_gemma":0.000008725935,"domain_scores_codex":[0.9983788,0.00007426866,0.0005041531,0.0005440677,0.0002735197,0.0002252508],"domain_scores_gemma":[0.9989678,0.00001931993,0.0004133173,0.0003481868,0.0001466875,0.0001046939],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001420163,0.004621421,0.01065355,0.009651144,0.002053324,0.000002207607,0.001662528,0.0001502799,0.0008986826,0.02102371,0.09687234,0.8509907],"study_design_scores_gemma":[0.0008606376,0.0002220308,0.001346423,0.004008482,0.00001338998,8.850783e-7,0.00001094848,0.000003889654,0.0003945568,0.000007980599,0.9927477,0.0003831352],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005095742,0.9966407,0.00004167122,0.00006111561,0.0003840597,0.0007572261,0.0007250849,0.000008738372,0.0008717791],"genre_scores_gemma":[0.0004595034,0.9925082,0.001430433,0.0003357153,0.0005245929,0.0006561367,0.003745301,0.00007899902,0.0002610827],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8958753,"threshold_uncertainty_score":0.999962,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069838467","doi":"10.1517/13543784.12.1.65","title":"Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Treatment of Major Depression","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Monoaminergic; Major depressive disorder; Tricyclic; Neuroscience; Psychology; Antidepressant; Monoamine neurotransmitter; Medicine; Psychiatry; Pharmacology; Psychotherapist; Serotonin; Mood; Receptor; Internal medicine","authors":[{"name":"Peter Farvolden","is_ca":true},{"name":"Sidney H. Kennedy","is_ca":false},{"name":"Raymond W. Lam","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2784800403397673,"gpt":0.4347821196305606,"spread":0.1563020792907933,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003962032,0.0003723323,0.000661785,0.0001352875,0.0001953898,0.00002157449,0.0001395639,0.0002207923,0.00000951996],"category_scores_gemma":[0.00006093703,0.0001829439,0.0001009179,0.0001775117,0.0001845881,0.00004843375,0.00002991783,0.000238074,6.486597e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009626638,"about_ca_system_score_gemma":0.0002032564,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000351923,"about_ca_topic_score_gemma":2.727841e-7,"domain_scores_codex":[0.9983091,0.0002060691,0.0005184914,0.000480707,0.0002976687,0.0001880104],"domain_scores_gemma":[0.9983848,0.0008976349,0.0003505392,0.0002438529,0.00004217124,0.00008095589],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008590535,0.0002498098,0.0001650044,0.0006219085,0.0002266654,6.119211e-7,0.0009942347,0.000003240012,0.00001218236,0.0009023104,0.00107608,0.995662],"study_design_scores_gemma":[0.002664976,0.0001107464,0.0005706851,0.00555962,0.00007347538,0.00009069655,0.0002740167,0.0000511102,0.00003768879,0.0001068667,0.9902906,0.0001694825],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001117058,0.9954171,0.0000583853,0.001391268,0.0004401034,0.002177012,0.00003981254,0.00001162866,0.0003530359],"genre_scores_gemma":[0.00004513701,0.9877639,0.009513705,0.0008315427,0.0003206083,0.0009398339,0.0004835941,0.00003803352,0.00006359475],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9954926,"threshold_uncertainty_score":0.7460235,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2732154709","doi":"10.1080/13543784.2017.1349753","title":"Alicaforsen for the treatment of inflammatory bowel disease","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Pouchitis; Inflammatory bowel disease; Vedolizumab; Ulcerative colitis; Placebo; Clinical trial; Gastroenterology; Internal medicine; Crohn's disease; Disease; Immunology; Pathology","authors":[{"name":"Vipul Jairath","is_ca":true},{"name":"Reena Khanna","is_ca":true},{"name":"Brian G. Feagan","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1765178096892389,"gpt":0.4477101717914101,"spread":0.2711923621021711,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002355825,0.0004006456,0.0009054831,0.0002253341,0.0002855815,0.00003817258,0.0003808063,0.0001909804,0.0001204836],"category_scores_gemma":[0.0005517038,0.0002329713,0.0009206464,0.00008061753,0.0005184204,0.00004282958,0.00005443952,0.000173275,0.0001043906],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003271691,"about_ca_system_score_gemma":0.001906592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001782646,"about_ca_topic_score_gemma":3.427569e-7,"domain_scores_codex":[0.9976514,0.0001254704,0.0006562354,0.0004696182,0.0008324037,0.0002648757],"domain_scores_gemma":[0.9965603,0.001168605,0.0004627,0.001149854,0.0002044314,0.0004540803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002039111,0.000435747,0.00001812207,0.005752192,0.0004723678,0.000008396991,0.0003573391,0.000004984483,0.000005839827,0.007773259,0.03576746,0.9492004],"study_design_scores_gemma":[0.0007851464,0.0003470988,0.0001135139,0.006073196,0.0000845059,0.000004891555,0.00001849432,0.0001567249,0.00003646599,0.0002258437,0.9919621,0.0001920492],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000006025654,0.9927664,0.00001677831,0.002521656,0.0004653535,0.003360258,0.0002312709,0.00002805138,0.0006041531],"genre_scores_gemma":[0.000005112137,0.9905079,0.000304118,0.0002824277,0.00119718,0.002539297,0.001408226,0.0000776314,0.003678101],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9561946,"threshold_uncertainty_score":0.9500294,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2905977615","doi":"10.1080/13543784.2019.1559295","title":"Rapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date","year":2018,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Treatment of Major Depression","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Major depressive disorder; Antidepressant; Treatment-resistant depression; Adverse effect; Investigational Drugs; Clinical trial; Medicine; Depression (economics); Psychiatry; Meta-analysis; Cognition; Psychology; Pharmacology; Internal medicine; Anxiety","authors":[{"name":"Renee‐Marie Ragguett","is_ca":true},{"name":"Carola Rong","is_ca":true},{"name":"Kevin Kratiuk","is_ca":false},{"name":"Roger S. McIntyre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1509173299690087,"gpt":0.4258168455622502,"spread":0.2748995155932416,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005426827,0.001124697,0.001778245,0.0007174324,0.0005249073,0.0001322455,0.0006957556,0.0006236102,0.000234408],"category_scores_gemma":[0.002552163,0.000910453,0.000634676,0.0006009561,0.0004750817,0.0005724151,0.0002431676,0.0004793122,0.0005415691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000387609,"about_ca_system_score_gemma":0.001837907,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004926673,"about_ca_topic_score_gemma":0.000002315184,"domain_scores_codex":[0.9940923,0.0004059983,0.001367816,0.001908465,0.001578408,0.0006470472],"domain_scores_gemma":[0.9945326,0.001351025,0.0007846818,0.001322446,0.0005981817,0.001411065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001002652,0.001828814,0.0003687063,0.01335148,0.001383267,0.00001846691,0.002283777,0.0001793461,0.0002379779,0.01352358,0.3513759,0.614446],"study_design_scores_gemma":[0.001802861,0.000996748,0.0003338552,0.04482702,0.0001617612,0.0000530244,0.00002850394,0.0004422457,0.0001874754,0.00117393,0.9491207,0.0008718897],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003316488,0.9847115,0.001005362,0.004699556,0.001856438,0.006094333,0.0007487352,0.0003376314,0.000214738],"genre_scores_gemma":[0.00008961886,0.9198373,0.04806636,0.004933232,0.005606047,0.007052774,0.01282616,0.0003672262,0.001221299],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6135741,"threshold_uncertainty_score":0.9993346,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2539921642","doi":"10.1080/13543784.2016.1254187","title":"Lomitapide for the treatment of hypertriglyceridemia","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Hypertriglyceridemia; Medicine; Microsomal triglyceride transfer protein; Acute pancreatitis; Triglyceride; Clinical trial; Intensive care medicine; Familial hypercholesterolemia; Internal medicine; Cholesterol; Lipoprotein","authors":[{"name":"Amanda J. Brahm","is_ca":true},{"name":"Robert A. Hegele","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1063324971780795,"gpt":0.4006755904027068,"spread":0.2943430932246274,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001811953,0.0004059577,0.001324654,0.0001684945,0.0001140323,0.00001074226,0.0001728499,0.0002386586,0.0001395784],"category_scores_gemma":[0.0003736457,0.0001873299,0.0008722448,0.0001638368,0.0002922387,0.0000470899,0.00001582023,0.00008987585,0.0001030459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001674015,"about_ca_system_score_gemma":0.0009602617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002258123,"about_ca_topic_score_gemma":1.810451e-7,"domain_scores_codex":[0.9981689,0.00008980397,0.0007056295,0.0004025692,0.0004004899,0.0002326011],"domain_scores_gemma":[0.9965817,0.002192962,0.0003699196,0.0005470058,0.0001251633,0.0001832747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007581294,0.0001805363,0.000002089661,0.001077639,0.000300522,2.077102e-7,0.0002613193,5.978697e-7,0.000002902559,0.01616604,0.04322679,0.9387056],"study_design_scores_gemma":[0.001550663,0.000354919,0.00000845863,0.005337861,0.0001151638,0.000007391674,0.00003999518,0.000008723681,0.00004741234,0.0005853763,0.99175,0.0001940544],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001945374,0.9917796,0.00008533763,0.003064122,0.001774142,0.002024689,0.0002583819,0.00003420221,0.0009775814],"genre_scores_gemma":[0.00000176549,0.9918278,0.0008106842,0.001033155,0.002789299,0.001456171,0.0005963848,0.00006321253,0.001421566],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9485232,"threshold_uncertainty_score":0.7639092,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2140368374","doi":"10.1517/13543784.15.11.1337","title":"Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Ezetimibe; Sterol O-acyltransferase; Medicine; Cholesterol; Microsomal triglyceride transfer protein; Pharmacology; Bile acid; Drug; Internal medicine; Lipoprotein; Very low-density lipoprotein","authors":[{"name":"John R. Burnett","is_ca":false},{"name":"Murray W. Huff","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07968378855267716,"gpt":0.3865278753482458,"spread":0.3068440867955687,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004791685,0.0009299482,0.00180399,0.0006782915,0.0002351452,0.0001475813,0.0002797817,0.0008728766,0.00004646803],"category_scores_gemma":[0.0001373567,0.0007656504,0.001051287,0.0004084319,0.00024149,0.0002772346,0.00005903056,0.0007909301,0.0004668602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004644929,"about_ca_system_score_gemma":0.0007514813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000441301,"about_ca_topic_score_gemma":8.131673e-7,"domain_scores_codex":[0.9957907,0.0002506638,0.001348605,0.001093294,0.0009834295,0.0005332596],"domain_scores_gemma":[0.9976308,0.0003569136,0.0006433405,0.0006937169,0.0002446571,0.0004305262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001012647,0.000375835,0.000008228826,0.00413262,0.0002078806,0.000001173167,0.000381879,0.00001085513,0.00009284999,0.0075369,0.01557385,0.9715767],"study_design_scores_gemma":[0.002021397,0.0003396919,0.0001899457,0.01328859,0.0001622086,0.0001230904,0.00003330468,0.00005558672,0.00006140976,0.0007972814,0.9823028,0.0006246189],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002790634,0.9893365,0.000190353,0.001760348,0.003308448,0.003659041,0.0001519928,0.000249583,0.00106466],"genre_scores_gemma":[0.000135869,0.9739582,0.0008127796,0.005535756,0.008417605,0.002434249,0.006492051,0.0002432892,0.001970178],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.970952,"threshold_uncertainty_score":0.9994795,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122024610","doi":"10.1517/13543784.13.4.403","title":"Ximelagatran: the first oral direct thrombin inhibitor","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Ximelagatran; Direct thrombin inhibitor; Medicine; Discovery and development of direct thrombin inhibitors; Coagulation; Anticoagulant; Thrombin; Intensive care medicine; Warfarin; Pharmacology; Atrial fibrillation; Dabigatran; Internal medicine","authors":[{"name":"Mark Crowther","is_ca":true},{"name":"Jeffrey I. Weitz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1352479400011735,"gpt":0.3960961936146366,"spread":0.2608482536134631,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003995912,0.0005725181,0.001303646,0.000263688,0.0003769821,0.00008844129,0.0002765347,0.0003299966,0.0003671192],"category_scores_gemma":[0.000265841,0.0003541145,0.0008902003,0.0005698631,0.0003105073,0.0001295694,0.00009901013,0.0004516522,0.0009075643],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003889857,"about_ca_system_score_gemma":0.0006690171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003403747,"about_ca_topic_score_gemma":0.000001391115,"domain_scores_codex":[0.9971648,0.0001570748,0.0008499642,0.0005824735,0.0009355017,0.000310114],"domain_scores_gemma":[0.9982094,0.0005704549,0.0003805443,0.0005486564,0.00008613723,0.0002048444],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001404431,0.0001286802,0.0001251825,0.01229275,0.001543282,0.00001864097,0.002117852,0.0001094297,0.00000231896,0.1570211,0.3747616,0.4517387],"study_design_scores_gemma":[0.0007898718,0.0001084871,0.00007935755,0.01235773,0.0000943596,0.00001661261,0.00003397644,0.000009962264,0.0000124878,0.0006838754,0.9854462,0.000367062],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002801972,0.9697092,0.000008141767,0.01869411,0.002586151,0.001773461,0.00003368466,0.0001799479,0.007012564],"genre_scores_gemma":[0.00003514647,0.9884939,0.0004034274,0.002643433,0.004982635,0.00009883274,0.001149904,0.00009500091,0.002097751],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6106846,"threshold_uncertainty_score":0.9998911,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2100830152","doi":"10.1517/13543784.17.11.1761","title":"Clazosentan: an endothelin receptor antagonist for treatment of vasospasm after subarachnoid hemorrhage","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Investigational Drugs","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Subarachnoid hemorrhage; Endothelin receptor antagonist; Vasospasm; Medicine; Cerebral vasospasm; Endothelin receptor; Antagonist; Placebo; Clinical trial; Randomized controlled trial; Receptor antagonist; Anesthesia; Internal medicine; Receptor; Pathology","authors":[{"name":"R. Loch Macdonald","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04050734314660269,"gpt":0.3031468555725261,"spread":0.2626395124259234,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004533931,0.0002329697,0.0003009806,0.0001104387,0.0002299957,0.00001028243,0.00008178855,0.00009441585,0.0002791209],"category_scores_gemma":[0.00002647653,0.0001921128,0.0001772549,0.0001239562,0.0002527964,0.0001060203,0.000008564194,0.00004784648,0.00009153729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001647884,"about_ca_system_score_gemma":0.0001935344,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005882481,"about_ca_topic_score_gemma":0.000001781112,"domain_scores_codex":[0.9987044,0.00003882132,0.0003677265,0.0003684293,0.0003131925,0.0002074176],"domain_scores_gemma":[0.9990489,0.000111583,0.0001145527,0.000345424,0.0001652241,0.0002143345],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01752547,0.03272624,0.05576486,0.0005431513,0.0007902537,0.0001774437,0.04263271,0.0001383707,0.5346392,0.215066,0.02323318,0.07676306],"study_design_scores_gemma":[0.01758163,0.01286721,0.04316598,0.0001619943,0.00009093727,0.0006161062,0.001025121,0.005114937,0.7021143,0.004783151,0.2113229,0.001155703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9831273,0.0008835137,0.0002743491,0.01185713,0.0005435448,0.001393866,0.0004550737,0.0001296389,0.00133557],"genre_scores_gemma":[0.974784,0.0002928804,0.01757148,0.001639543,0.0009751957,0.001034245,0.001803918,0.00004087359,0.001857857],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2102828,"threshold_uncertainty_score":0.7834135,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2149879542","doi":"10.1517/13543784.15.5.507","title":"The potential of clusterin inhibiting antisense oligodeoxynucleotide therapy for prostate cancer","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Clusterin; Prostate cancer; Prostate; Gene silencing; Cancer research; Medicine; Cancer; Apoptosis; Oncology; Internal medicine; Biology; Gene","authors":[{"name":"Hideaki Miyake","is_ca":false},{"name":"Isao Hara","is_ca":false},{"name":"Masato Fujisawa","is_ca":false},{"name":"Martin Gleave","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05709997216926325,"gpt":0.3872571996764856,"spread":0.3301572275072223,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003967335,0.0004772533,0.001132808,0.0002005819,0.0002681382,0.00003973453,0.000224649,0.0002624932,0.00003243132],"category_scores_gemma":[0.0002435212,0.0003295084,0.0006246889,0.0002278187,0.0005454027,0.00005154814,0.0001058929,0.0002757664,0.00001152776],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001933797,"about_ca_system_score_gemma":0.001119873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006298684,"about_ca_topic_score_gemma":0.000002419908,"domain_scores_codex":[0.9971001,0.0002470498,0.001139807,0.0005717921,0.0005530458,0.0003882271],"domain_scores_gemma":[0.9976243,0.0006858951,0.0007918344,0.0004434014,0.0002819319,0.0001726655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004051393,0.0001987908,0.00001851709,0.005702801,0.0002868617,0.00001156074,0.0003201962,0.00007881269,0.000293131,0.00198306,0.04451758,0.9461836],"study_design_scores_gemma":[0.001374651,0.0002198103,0.0001261779,0.01083166,0.00004815098,0.00006585997,0.00005109139,0.0003688291,0.000123321,0.0003850682,0.9860942,0.0003111153],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006137472,0.9917268,0.00003569165,0.002052505,0.001497895,0.00306076,0.0006291395,0.00006318777,0.0003203192],"genre_scores_gemma":[0.0001546424,0.9925117,0.000899113,0.0009093072,0.00166092,0.001784423,0.00139927,0.0001284298,0.0005521264],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9458724,"threshold_uncertainty_score":0.9999157,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2094081851","doi":"10.1517/13543784.2013.840289","title":"Investigational drugs for onychomycosis","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Terbinafine; Medicine; Adverse effect; Drug; Dermatology; Drug development; Pharmacology; Clinical trial; Intensive care medicine; Antifungal; Itraconazole; Internal medicine","authors":[{"name":"Aditya K. Gupta","is_ca":true},{"name":"Fiona C. Simpson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1200528077595505,"gpt":0.4104213781560894,"spread":0.2903685703965388,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001895178,0.0008875525,0.00164962,0.0004967003,0.0003158943,0.0001054952,0.0002965486,0.0005085514,0.0007497022],"category_scores_gemma":[0.0004284346,0.0007044702,0.001194649,0.0004402001,0.0003364539,0.0002101282,0.0000765767,0.0004021796,0.001387812],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006155817,"about_ca_system_score_gemma":0.002051824,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000046782,"about_ca_topic_score_gemma":1.823125e-7,"domain_scores_codex":[0.9960744,0.000154731,0.001097276,0.001044962,0.001116446,0.000512158],"domain_scores_gemma":[0.9965543,0.0008658801,0.0005701819,0.0006529879,0.0003609359,0.0009957736],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004920607,0.00052327,0.00002609335,0.00469287,0.0008327342,0.000002822302,0.0002446454,0.000001714009,0.000001263576,0.0302394,0.2788247,0.6845613],"study_design_scores_gemma":[0.00167667,0.0002675085,0.00006552671,0.01616841,0.0002024956,0.00002242435,0.00003684399,0.00004990063,0.00001183415,0.004392047,0.976513,0.0005933667],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001674293,0.988546,0.00002757294,0.002703356,0.001324034,0.003963404,0.0008477283,0.0001677335,0.002403484],"genre_scores_gemma":[0.00001127931,0.9610016,0.006183058,0.004122177,0.002285453,0.006283778,0.01722085,0.0001829804,0.002708827],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6976883,"threshold_uncertainty_score":0.9995406,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}